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ABSTRACT
REACTIVE HETEROCYCLES FOR EXAMINING POLYKETIDE BIOSYNTHESIS
SEPTEMBER 2013
GITANJELI PRASAD, B.Tech., INSTITUTE OF CHEMICAL TECHNOLOGY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Nathan A. Schnarr
Polyketides are a class of natural products that exhibit remarkable structural and
functionally diversity and are highly sought after due to their medicinally important activities.
For many decades now, polyketide synthases (PKSs), the mega-enzymes responsible for
biosynthesis of polyketides have been the focus of extensive investigation to make new
polyketides by polyketide engineering strategies. While there are many established methods to
investigate polyketide enzymes and biosynthesis mechanisms, they have substantial
shortcomings that have limited the extent of success with polyketide engineering efforts.
This thesis focuses on developing simple, flexible yet powerful tools for examining
polyketide biosynthesis by overcoming some deficiencies in currently used techniques. Reactive
heterocylces have been designed for direct labeling of key polyketide synthase enzymes to
provide a direct insight into its functions and mechanisms. First β-lactones and then β-lactams
have been used as small molecule probes to perform site-specific labeling of acyl carrier
proteins and further used for mechanistic interrogation of key steps in polyketide biosynthesis.
The utility of these probes has been demonstrated by comparison to traditional probes and has
been successfully applied to examine substrate selectivity of keto synthases, key enzymes in
polyketide biosynthesis. The applications of the tools described in this manuscript only scratch
the surface of their capabilities and are expected to significantly aid in the study of new and
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existing PKS systems leading to improved understanding of how these extraordinary
biosynthetic machines function.
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CHAPTER 1
INTRODUCTION

1.1. Polyketides and Polyketide synthases

Polyketides are a diverse class of natural products found in soil and marine bacteria as
well as fungi and higher plants. In addition to exhibiting a large range of structural and
functional diversity, they are a rich source of biologically active and medicinally relevant
compounds. Despite the vast structural diversity observed in polyketides, their biosynthesis
proceeds by simple, repetitive condensations of acetate or propionate type monomers in a
manner that closely resembles mechanism of fatty acid synthases (FASs)

1-3

. They are

constructed by multi-enzyme assemblies termed as polyketide synthases (PKSs) that assemble
simple acyl extender units in a linear fashion and yet this simple foundation is capable of
producing molecules with enormous variation in structure and function. Polyketides can be
broadly classified into groups based on how their parent polyketide synthases function. Iterative
PKSs use the same set of active sites to build a polyketide chain and perform processing on them
to form aromatized or highly oxidized products. The same module repeatedly catalyzes chain
elongation and modification. In contrast, modular PKSs consist of sequentially linked groups of
active sites called modules to perform chain elongation and other transformations to give more
reduced products that often undergo macrocyclization.

1.1.1 Importance and Scope of PKSs

A large number of polyketides have been used as commercial pharmaceutical products
and include numerous antibiotics (e.g. erythromycin, tetracycline), anticancer agents (e.g.
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doxorubicin, epothilone B), immunosuppressants (rapamycin), antifungal (e.g. amphotericin),
cardiovascular agents (e.g. lovastatin) and veterinary products(e.g. tylosin) (Figure 1.). Over the
past few decades, primarily due to their importance as pharmaceutical agents, polyketides have
been the focus of extensive investigation1,2. The prevailing problem of anti-bacterial resistance
towards existing antibiotics has highlighted the need for new and effective therapies. There has
been a troubling decline in emerging therapeutic leads in the pharmaceutical pipeline over the
past few decades, resulting in increased demand for newer sustainable methods for drug
discovery.
Despite significant success in synthetic drug development efforts, natural systems are
still a rich source for potent small molecule therapeutics. Although polyketides are an attractive
target for drug discovery, their structural complexity impedes their synthetic preparation. The
total synthesis of such natural products is extremely difficult, laborious and suffers from poor
yields. Synthetic modification of existing scaffolds has some promise but can be extremely labor
intensive and is limited in the range of transformations that can be selectively performed on
these complex natural products.
PKSs produce compounds with high medicinal activity and their structural and functional
modularity has raised the possibility that polyketide biosynthesis pathways could be rationally
reprogrammed by combinatorial manipulation to generate novel compounds of therapeutic
significance.7-13 Many aspects of polyketide engineering can be manipulated to achieve
diversification. Product chain length variation can be achieved by varying the total number of
modules in the PKS. Novel functionalities can be incorporated by introducing a variety of new
primer and extender units, subject to the condition that substrate selection is controlled by AT
enzymes. The oxidation state of the β-carbon as well as the stereochemistry can be modified by
manipulating the DH, KR and ER of a module. Success in this direction is highly dependent on the

2

basic mechanistic understanding of the manner in which these molecules are biosynthesized 13
and significant efforts have been made to use PKSs as platforms to generate newer and diverse
drugs and therapeutics.

Figure 1. Examples of commercial pharmaceutical drugs
Particularly in modular PKSs, there exists a distinct linearity in the protein structural
organization and their function. This makes them a powerful model for efforts towards design
and engineering of polyketide biosynthesis. Extensive work has been done with the aim of
mixing and matching modules and domains from heterologous PKS proteins. Another approach
is to use domain deletion, addition and domain swapping to generate novel, ‘’unnatural’’
polyketides. Numerous studies have been aimed to better our understanding of natural systems
and in turn, improve our ability to manipulate them

3

14-17

. However, these efforts have only

achieved moderate success and are often faced with the issue of decreased productivity which
could be due to structural instability of the engineered protein, sub-optimal chemistry within
the altered module or problems with inter-modular transfer of polyketide intermediates in the
assembly line

14-17

. Another major hurdle is the intrinsic specificities within key enzymes

responsible for production of polyketides which arises from lack of understanding their natural
preferences. Therefore there is an urgent need to explore more reliable means of investigating
the molecular basis for key aspects of substrate selectivity of enzymes, intermodular
communication and intermodular chain transfer.
The research described in this thesis is aimed towards developing a set of highly desired
molecular tools to facilitate the study of polyketide biosynthesis and ultimately improve
polyketide engineering.

1.2. Modular Polyketide Construction

Modular PKSs are assemblies of covalently connected catalytic domains in the form of a
large polypeptide. Each domain catalyzes a single chemical transformation and are collectively
organized into modules. Each module, composed of its set of domains, brings about one round

Figure 2. Proposed mechanism for polyketide formation in modular PKS
4

of chain elongation to the polyketide backbone (Figure.2). The variety in the organization of
these large protein assembly lines gives rise to polyketides of great structural diversity.
Chain growth is initiated by a loading module, followed by a number of extender
modules that make up the body of the polyketide chain and the process is terminated by a
release module. The first module contains a loading domain often composed of a loading acyl
transferase (AT) domain and a loading acyl carrier protein (ACP) which loads the first extender
module with an acyl substrate. Each extender module must contain at the least, an AT, ACP and
ketosynthase (KS) domain to function. In addition to this, they may also contain combination of
β-carbon processing enzymes such as a ketoredcutase (KR) domain, a dehydratase DH) domain,
and an enoylreductase (ER) domain. The composition of these domains varies widely across
different PKSs. The final module in this sequence generally contains a C-terminal thioesterase
(TE) domain which releases the final polyketide product from the PKS 4-7.
Polyketide synthesis proceeds in a manner that resembles an assembly line with
individual components performing distinct tasks in a stepwise fashion to a specific product
repeatedly. A starting unit in the form of a Coenzyme A derivative such as Propionyl-CoA is
loaded onto the terminal thiol of the phosphopantetheinyl arm of the ACP of loading domain by
the AT of the loading domain to form a thioester-bound acyl fragment. Chain extension begins
with passing of the acyl fragment from the ACP to the cysteine active site of the first extender
module KS (Figure 2). The AT loads the ACP of this module with an appropriate malonatederived extender unit. The AT strictly controls the choice of extender unit for a particular
module and hence acts as gate keeper. The KS of this extender module catalyzes a
decarboxylative Claisen condensation between its acyl unit and the extender unit on ACP
forming an ACP-bound β-ketothioester product. The β-keto residue may then undergo
sequential processing by KR to from an alcohol, DH to form an alkene and ER to form a
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saturated chain. Depending on the module, a given elongation step may stop at any of these
intermediate products (keto, hydroxyl, enoyl) or result in the fully reduced β-carbon product.
Upon completion of these steps, the chain is passed from ACP of this module to KS of next
downstream module and the sequence of growth and processing repeats until the desired
polyketide product is formed. Once the product is completed, the chain is passed to the TE
where it catalyzes release of the product either by hydrolysis or cyclization. The choices of
building blocks made by each module and the number and types of domains within each module
catalyzing postcondensation reactions dictate the chemical functionality at each carbon atom in
the final product.

1.2.1. 6-derythronolide B synthase (6-DEBS)

The most well studied modular PKS is 6-deoxyrythronolide B synthase (DEBS) which is
responsible for assembly of 6-deoxyerithronolide B (6-DEB), the macrolide precursor to

Figure 3. 6-deoxyerythronolide B synthase (DEBS)
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erythromycin A. 6-DEBS has become the archetype of modular PKSs. The entire DEBS has been
successfully expressed in the heterologous hosts such as Escherichia coli. Recombinant strains of
E.coli have been engineered specifically to optimize the expression of the DEBS proteins4-6. The
ability to efficiently express PKS proteins in engineered heterologous hosts has provided a
greatly simplified platform to perform PKS investigations.
DEBS consists of six modules grouped into 3 large polypeptides DEBS1, DEBS2 and
DEBS3 (Figure 3.) where each contains two modules. The loading didomain consisting of ACPL
and ATL, loads propionyl-CoA onto the KS of the first extender module. The AT of the first
module loads the ACP of that module with methylmalonyl-CoA as an extender unit. Similarly, all
other ATs in DEBS incorporate a methylmalonyl-CoA unit onto their respective ACP. All six
modules harbor a KR, while KR of module 3 is inactive. Module 4 carries a DH domain and ER
domain as well as a TE at the C-terminus for releasing the final macrocycle. As in all PKSs, the
precise composition and specificity of these domains provide the diverse stereochemistry and
oxygenation patterns in the final macromolecule. Much of what is known about the molecular
mechanisms of modular PKSs is derived from extensive investigations of the DEBS. These large
PKS modules were not very suitable for performing in-depth investigation of mechanistic steps
of each individual domain. A substantial advancement in this area came from limited proteolysis
studies that revealed highly conserved interdomain boundaries at which individual modules
could be further disconnected to form fully functional PKS subunits. Upon proteolytic cleavage,
functional domains are released and their exact domain boundaries are calculated by N-terminal
sequencing analysis

12,13

. This gives rise to domains such as KS-AT, ACP, TE, AT-ACP loading

didomain and other beta carbon processing sub-units as stand-alone entities. For instance, by
identifying cleavage sights located in the amino acid sequence, it was possible to express a
homodimeric [KS][AT] didomain possessing full catalytic activity that could be used for stepwise

7

structural and functional analysis

13

. This approach has been used extensively to perform in-

depth analysis of DEBS enzymes and their functions which in turn have helped understand the
working modular PKSs.

1.3. Traditional Methods for PKS investigations

In the past, a number of approaches have been utilized to investigate various aspects of
the PKS biosynthetic machinery. Some key approaches have been described in the following
sections. Despite having their uses in some areas of application, they suffer from certain
shortcomings in other areas which reinforce the need for newer tools for investigation of PKSs.

1.3.1. Radiolabeling

For many decades now, radiolabeling has been extensively used for in vivo as well as in
vitro PKS biosynthesis investigations. DEBS is the most well studied PKS using these techniques.
Traditionally, it was used for incorporation in vivo of radiolabelled substrates to probe the
mechanism of biosynthesis by analyzing of the final product18a, b. The radiolabelled substrates,
[2-2H2, 2-13C] propionate and [2-2H2, 2-13C] methylmalonyl-CoA were fed to the bacterial cultures
of S. Erythrea, and the polyketide product were isolated and analyzed by scintillation count and
using

13

C NMR. The incorporation of the radiolabels into the erythromycin macrolide gave

insight about the mechanism of condensation and chain extension. The observation of specific
stereochemistry such as generation of D-methyl groups in the carbon skeleton of the final
molecule provided strong evidence for analogy to fatty acid biosynthesis. However the scope of
this approach limited due to poor yields in vivo, inability to isolate crucial intermediates and
failure to address key aspects such as protein-protein and protein-substrate interactions,
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substrate recognition of individual domains and precise mechanism of individual steps in chain
transfer and elongation.

1.3.1.1 Radiolabeling with 6-DEBS

A more direct way of gaining insight into these key questions involved carrying out
experiments with PKS proteins in vitro which made it possible to probe the PKS multienzymes
under controlled conditions such as temperature, buffer, and in the absence of metabolic
constraints. The use of heterologous hosts such E. Coli to express these proteins in good yields
has greatly facilitated this approach. Additionally, in vitro environments provide a cleaner
background for the isolation of polyketide products. To facilitate this approach, the DEBS was
shortened into smaller model systems by moving the thioesterase (TE) domain from DEBS3 to
the end of DEBS1 and DEBS2 to form DEBS1+TE and DEBS2+TE resulting in premature release of
the chain at the triketide stage

20

. This revolutionary approach introduced an efficient

alternative to working with these enormous intact protein systems. The truncated modules
were incubated with radiolabelled coenzyme A derivatives to obtain chain extension and release
of the cyclized products which were analyzed by thin layer chromatography with
autoradiography or phosphorimaging. For example, incubation of module 2+TE with appropriate
analogue of the natural diketide-SACP substrate of KS of DEBS module 2 and MeMal-CoA for the
ACP gives an acyclic triketide that is released from the enzyme by TE catalyzed cyclization to
yield triketide lactone (Figure 4.). The radiolabeled product were extracted out of the samples
and analyzed by liquid scintillation counting which quantifies the amount of radiolabeled
product formed. The amount of radiolabeled product provides measure of enzyme loading and
substrate turnover.

9

Figure 4. Conversion of Diketide-SNAc to Triketide lactone
The use of isolated PKS enzymes has made it possible to perform extensive biochemical
analysis of substrate specificity, kinetics, and stereochemical preferences

14-17, 20

. However, an

intrinsic limitation of in vitro studies is the greatly reduced (~1µg) quantities of polyketide
products that are ordinarily generated in such experiments, which require the independent
preparation of authentic reference samples by laborious total synthesis. Additionally, the high
cost of required coenzyme A thioesters needed for chain extension prohibits larger scale in vitro
synthesis of polyketides.
As described previously, limited proteolysis studies yielded all the individual domains
from DEBS. Isotopically labeled SNAc thioesters are extensively used along the same lines as
described above with these stand-alone protein units by loading the ACP and KS domains and
performing chain elongation

21

. By far, the most significant advantage of this method is the

ability to carry out multiple turnover experiments with discrete ACP and KS-AT domains in the
absence of TE which was previously necessary to release covalently bound products from the
enzyme.

1.3.1.2. N-acetylcysteamine thioesters

The discovery of simple synthetic mimics of coenzyme A substrates in the form of Nacetylcysteamine(SNAC) thioesters brought about a great advancement in this field. These SNAC
thioesters were more economical, easily prepared and demonstrated to be good substrates of
PKS enzymes 22. The N-acetylcysteamine (NAC) is a truncation of the coenzyme A side chain and
10

hence acts as the recognition motif for PKS enzymes. In the first report, the methylmalonyl-SNAc
was incubated with DEBS3 along with a [13C] labeled diketide primer to test product formation.
The organic extract of the reaction was analyzed by 13C NMR and confirmed the formation of the
expected triketide lactone. This experiment confirmed the acceptance of these SNAc thioesters
as good substrates for PKS enzymes, following which, a large number of other SNAc thioesters
have been prepared and widely used as coenzyme A substitutes.
As an example of radiolabeling experiments of DEBS hybrid modules with use of SNAc

Figure 5. Analysis of radiolabeling experiments
(A): Radio SDS−PAGE of [14C] 2-methyl-3-hydroxylpentynoyl-SNAc labeling of M3M5TE hybrid
module and ACP2. (B): Radio SDS−PAGE of [14C]Methylmalonyl-CoA labeling of M3M5TE and ACP5
and (C): Radio TLC Triketide lactone formation by DEBS hybrid module. 21
thioesters and their analysis, Figure.5 outlines an assay performed with hybrid module
containing ACP3, KS5 and TE of DEBS (M3M5TE). The module is incubated with substrates for
ACP and KS and the labeled proteins are visualized by radio-SDS-PAGE whereas the small
molecule output of triketide lactone is visualized by radio-TLC.
In all, radiolabelling techniques have been vastly used to probe the activities and
behavior of various PKS enzymes. The major drawback of this approach is the prohibitively
expensive reagents that limits the availability of diverse substrates and restricts applications to

11

smaller scales. Here lies the gap in biotechnology to develop simpler strategies to investigate
PKS enzymes and biosynthesis which can overcome the handicaps discussed above.

1.3.2. Mass spectrometry

More recently, mass spectrometry has emerged as a powerful tool for biological analysis
as a result of its sensitivity, accuracy and speed and has been used for structure elucidation of
polyketides and observing aspects of PKS biosynthesis

29-34

During the biosynthesis of

polyketides, substrates, intermediates and side products are covalently tethered to the PKS,
introducing mass changes, making these biosynthetic systems ideal candidates for interrogation
by large molecule mass spectrometry. MS can be used to understand substrate tolerance,
timing of covalent linkages, timing of tailoring reactions and the transfer of substrates and
biosynthetic intermediates from domain to domain.
Controlled limited proteolysis has been used to release and separate entire functional
domains from modular PKSs such as DEBS which enables to probe the function and organization
of the domains within the intact modules 12,13. For instance, DEBS hybrid units such as DEBS1-TE,
DEBS3 and the DKS(loading didomain+module1, called diketide synthase) were subjected to this
method 31. The intact muti-domain units were digested with trypsin and monitored by LC-MS to
separate the fragments and analyze them using sequence alignments and N-terminus
sequencing

to

identify

the

separated

domains.

For

instance,

the

DEBS1(loading

didomain+module1+module2) proteolysis gave rise to many single and multidomains such as
KS1, AT1, TE, KR1, ACP2-TE, ATL-ACPL(AT and ACP of loading domain). Similarly, the proteolysis
of the DKS unit gave another array of domains. The ability to isolate these individual domain and
domain pairs enabled the study of acylation specificities for each individual AT, ACP and KS. For

12

instance, Propionyl-CoA, the native substrate for the DEBS loading module, was incubated with
intact DKS followed by proteolysis to release the domains for analysis. By analysis of mass peaks,
it was revealed that propionyl units were specifically loaded onto ATL-ACPL and KS1 but not on
AT1, KR1, ACP1 or TE domains. This indicated that propionyl-CoA is not a suitable substrate for
the extender AT1 and ACP1 domain. Experiments with the non-natural substrate n-butyryl-CoA
with DEBS1 and DKS showed similar results also indicating sufficient mass accuracy to
distinguish between propionyl and butyryl groups. In this manner, numerous substrates studies
have been conducted with these domains by observing the stable acyl intermediates.
Along similar lines, individual domains such as ACP, TE and [KS][AT] didomians were
engineered and expressed in E.Coli 13. A method was developed to achieve complete proteolysis
of didomain to enable the direct detection of covalently bound substrates by MS. For example,
in an experiment, the substrate specificity of KS from DEBS module 3 was examined by pairwise
combinations of various di- and tri-ketide-SNAc thioesters and observation of KS acylation. The
specificity for each substrate was measured by the relative proportions of each acyl-enzyme
species, as determined by LC-MS (Figure 6.). Also, by doing time points of incubation, relative
rates of acylation and step-wise kinetic analysis can be performed. KS-catalyzed chain
elongation in the presence of the methylmalonyl-ACP was performed with these different KS
substrates. The use of discrete ACP and [KS][AT] domains allowed multiple turnover
experiments by use of excess ACP. Direct proteolysis of the mixture followed by LC-MS analysis
provided peptide fragment peaks corresponding to the KS and ACP domains at various stages of
polyketide extension. Kinetic analysis provides detail insight into comparative rates of ACP
loading, KS acylation by diketide substrate and chain elongation event. One major advantage of
this method over traditional radiolabeling is that both acylation and elongation can be

13

monitored simultaneously. It has also eliminated the need to use expensive radiolabels for PKS
examinations.

Figure 6. [KS][AT] didomain acylation observed by LC-MS
In this manner, mass spectrometry has grown into powerful yet sensitive and reliable
method to assay ACP and KS acylation events. It has been used in limitless application including
study of substrate specificities of PKS enzymes, examination of various heterologous ACP-KS
ACP
pairs, kinetic evaluation of chain elongation steps and PKS protein chemistry
chemistry.
Despite many improvements over traditional techniques, mass spectrometry has some
shortcomings. Firstly, the full PKS modules that are about 300 kDa in size cannot be used in this
assay due to which smaller subunits are used as substitutes such as the [[KS][AT]
KS][AT] didomain. It
remains unclear whether such a substitution has any effect on actual PKS enzyme specificities.
Secondly, there is the question of effect of substrates on ionization potentials when proteolysis
is performed. This could adversely affect data interpretation and its reproducibility. Lastly and
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most importantly, substrates with high hydrophobicity are susceptible to solubility issues which
affect the signal in MS which limits the chemical diversity of substrates.

1.4. Hypothesis

As summarized in this chapter, mass spectrometry and radiolabeling strategies
combined with genetic engineering and molecular biology tools, have been successful for many
aspects of PKS investigations. The high reagent cost, limited substrate availability in case of
radiolabeling, and inability to perform direct PKS investigations using MS methods restrict their

Figure 7. holo-Acyl Carrier protein with Ppant arm
use in medium to high-throughput applications essential for investigating the rapidly emerging
new PKS systems. There exist many reliable methods to study KS substrate specificities by
directly loading the KS active-site which have been discussed above. This has enabled enormous
KS-centered analysis of chain elongation kinetics, inter-domain and inter-modular chain transfer
but little is known about other aspects, for example, the tolerance of KS towards diverse nonnatural extender units.
Nearly all biosynthetic steps associated with modular PKS systems rely on acyl-ACPs.
Therefore, functional analysis of each enzymatic event would require a robust method of
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generating and monitoring their fate. Despite the central and highly functional role played by
ACPs in polyketide biosynthetic processes, ACP-based PKS examination strategies are highly
underdeveloped mainly due to insufficient techniques to perform ACP modifications. The strict
AT specificities limit the variety of natural substrates for ACP and have prevented efforts of ATmediated modification of ACP using synthetic substrates. Traditionally, ACPs are modified by
small molecules via acylation of coenzyme A and subsequent PPant transferase-catalyzed
transfer to the apo form of ACP. Synthesis of these CoA analogues is labor intensive, costly, and
scale-up is tricky23-26. Another method utilizes the CoA pathway to introduce thioether-linked
substrates onto the ACP via generation of synthetic CoA analogues

27-29

. While a very powerful

approach, this technique requires extensive genetic manipulation and resulting thioesters
cannot be processed by PKS enzymes that recognize thioester linked species and therefore are
of limited use to PKS investigations. As genomic-based technologies continue to supply an
abundance of new PKS systems, there is an urgent need for complimentary methods using
simple, reliable and structurally flexible ACP-acylating agents.

Figure 8. Acyl Carrier Protein enzyme partners
We were convinced that ACPs, with their ability to interact with many proteins and carry
out a range of vital functions, were the ideal choice for introducing chemical substrates, labels,
and intermediates onto PKSs (Figure 7, 8). To achieve this, there is a need to develop a method
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to introduce novel substrates with wide structural diversity onto the ACP and generate
functional donor-ACPs to utilize them in PKS investigations. We reasoned that a suitable strategy
would be to design appropriately reactive small molecule functionalities and target them
towards a biomacromolecular site within the PKS. The terminal thiol PPant of ACP is a unique
nucleophile in PKSs and being positioned on a long flexible prosthetic arm imparts it great
accessibility and distinctive reactivity to ACPs in the presence of a multitude of other
nucleophiles such as cysteine, serine, lysine and tyrosine.
As outlined in the rest this document, our aim is to target the PPant arm of the acyl
carrier protein. The hypothesis is that, with the right electrophilic partner for this terminal thiol
using small molecules, we can achieve site-specific labeling and generate acyl-ACPs to gain a
direct access into the PKS machinery.
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CHAPTER 2
DIRECT ACYLATION OF CARRIER PROTEINS WITH β-LACTONES

2.1 Introduction

Acyl carrier proteins are critical components of fatty acid and polyketide biosynthesis .
Their primary function is to shuttle intermediates between active sites via a covalently bound
phosphopantetheine arm. Majority of biosynthetic steps involved in modular PKS systems rely
on acyl-ACPs 3. Therefore, a reliable method for generating acyl-ACPs and monitoring their fate,
will greatly aid step-wise functional analysis of PKSs. Our hypothesis was that the Ppant group
may be uniquely reactive, given an appropriate electrophilic partner, and therefore, targetable
for direct acylation. We reasoned that small molecules capable of acylating this prosthetic group
will provide a simple and reversible means of introducing novel functionality onto carrier protein
domains. We were interested in using β-lactones for directly labeling acyl carrier proteins (ACPs)
via the phosphopantetheine(Ppant). This strategy was particularly appealing since, βHydroxythioesters, formed by addition of the PPant thiol to a β-lactone, are common
components of polyketide intermediates.
There is substantial precedence of electrophilic groups used as partners for nucleophiles
in biological systems. Many biologically active natural products have electrophilic functional
group cores that target nucleophilic residues as a part of their mechanism of action. Some well
documented examples of such a feature are lipstatin, penicillin, cerulenin, orlistat

1,2

. They are

perfect examples of how electrophilic groups such as the carbonyl group, the epoxide and the
electron deficient alkene are protein-reactive chemical entities. These electrophiles covalently
modify their nucleophilc targets to inhibit or deactivate them. The lipstatin family of natural
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products features a four-membered β-lactone ring. The chemical reactivity of this ring is the
basis of their biological activity. The catalytic active-site serine nucleophile of their target
enzyme attacks the electrophilic carbonyl of the β-lactone to form a β-hydroxy serine ester. In
case of lipstatin, it has been experimentally confirmed that the reaction is exclusively at the
carbonyl site giving an ester and not an ether product3.

2.1 Results and discussion

Figure 9. β-lactone for ACP-acylation
We began by preparing an alkyne-bearing β-lactone, compound 1 (Figure 9.)5, for
performing the ACP-acylation approach. The ACPs used for this study were from modules 2
(ACP2) and 3 (ACP3) of the 6-deoxyerythronolide B synthase (DEBS) that were isolated,
overexpressed and purified in both apo and holo forms, using BL21 and BAP1 cells, respectively.
To test selective Ppant acylation, the reagents were incubated with these isolated holo- and
apo-ACP domains. The criteria for a successful reagent were to exhibit selectivity for the holo
structures, without nonspecific acylation of the apo ones. Competition from nucleophiles
present on other common PKS domains was a primary aspect to be observed carefully. We were
aware that, to be truly useful, our probes must avoid reaction with them. Prior studies report KS
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active site to be competent nucleophiles for β-lactone ring-opening 6, as a result, KS-AT
didomain from DEBS module 6 (KS-AT6) was overexpressed and purified 7-8.

There is precedence in this matter, where minimal reactivity between compound 1 and
the KS domain of bacterial fatty acid synthase was observed 6. We were interested in testing the
purified DEBS KS domain in this respect to see how it behaved in these conditions. In this
manner, the stage was set to examine both efficiency and selectivity of ACP-acylation with βlactones.
As discussed earlier, tandem proteolysis-mass spectrometry has emerged as a powerful
means of detecting PKS-bound small molecules in vitro

9-11

. By extensive trypsinolysis of apo-

and holo-ACPs, a series of peptide fragments were produced, including one containing the
conserved DSL motif, to which the Ppant is attached in samples derived from BAP1 as
determined by LC-MS. Incubation of holo-ACP2 and -3 with varied equivalents of 1 at pH 7 for 1
h followed by exhaustive trypsinolysis and LC-MS, to determine the fraction acylated, produced
saturation curves which indicated that a roughly 50-fold excess of lactone is required for

Figure 10. Saturation curves of alkyne β-lactone
ACP3 (yellow), ACP2 (blue), and KS-AT6 (red) treated with compound 1, trypsinized and
analyzed by tandem proteolysis-mass spectrometry. Equivalents of lactone are per protein
molecule. Each data point is the average of three experiments. Standard deviations are shown
as black error bars. Lines are added for clarity.
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complete acylation (Figure 10.). The results were that both apo-ACPs showed no acylation with
50 equiv of lactone, providing further evidence that the reaction is occurring on the Ppant arm
as this is the only difference between the apo and holo forms of ACP. In comparison, the
saturation curve for KS-AT6 showed 25−50% less acylation than ACP for the range of lactone
equivalents tested. Most importantly, at 10 lactone equivalents, the ACPs were approximately
35−50% loaded while the KS was mostly unreactive after 1 h of incubation. Standard deviations
for these experiments were generally within 1−4% suggesting that the differential reactivity
observed was genuine.
By means of tandem proteolysis/LC-MS it was confirmed that the acylation occurs at
the PPant group. However, not all proteolysis products readily ionize under the conditions used.
In addition, we could not rule out the potential for acylation of the peptide fragments over the
intact protein. As an alternative, a gel-based assay was designed according to previous work by
Sieber and co-workers 6. Each ACP (apo and holo) and KS-AT6 was incubated for 1 h with 10 e
SDS-PAGE analysis of the resulting mixtures showed bright fluorescent bands corresponding to
holo-ACP2 and -3 while the apo-ACPs and KS-AT6 displayed only background fluorescence
(Figure.11.). These results provide initial indication that β-lactones can be selective for ACP over
KS as well as avoid other potential competing residues such as surface cysteines, serines, and
lysines.quiv of 1 followed by 1,3-dipolar cycloaddition (“click”) reaction with rhodamine azide 1214

.
At this point, the functionality of the acyl-ACP intermediates needed to be established

along with the evidence of thioester over thioether formation. Preloaded ACP2 and ACP3 (10×
compound 1) were mixed with KS-AT6. After 1 h, the click reaction was performed as before and
the proteins separated by gel electrophoresis.
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Figure 11. PAGE analysis of fluorescently labeled DEBS ACP3, ACP2, KS-AT3, and KS-AT6
Reaction with compound 1 and subsequent click reaction with rhodamine-azide. Lanes are
marked above with the corresponding protein component. Markers to the left indicate
expected bands for the indicated species. The right two lanes depict transfer of the
acylation product from preloaded ACP to KSAT indicating that the intermediates are
functional. β-Lactone was applied at 10× relative to protein unless otherwise noted. ACP2
contains a C-terminal linker region accounting for its larger mass.
Bright bands corresponding to the KS-AT6 didomain indicate that the βhydroxythioester is efficiently transferred from the ACPs (Figure 11). It should be noted that
direct KS-acylation is not observed under the conditions used in these experiments.
The next step was to examine β-lactone behavior with a higher level of biological
complexity for which we overexpressed and purified apo and holo forms of the intact module 2
from spinosyn synthase (SpnB). This particular module was chosen because it contains KS, AT,
DH, ER, KR, and ACP domains which represent the vast majority of synthase components
present in a given assembly. Both apo and holo forms of spinosyn module 2 were incubated for
1 h with 10, 50, and 75 equiv of 1 followed by “click” reaction with rhodamine azide and PAGE
analysis as before (Figure 12.). Again, the only difference between apo and holo forms was the
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Figure 12. SDS-PAGE analysis of fluorescently labeled SpnB
absence or presence of the Ppant group, respectively. To our satisfaction, only the holo-protein
showed significant fluorescence indicating that Ppant-thiol is the only competent partner for
acylation among a multitude of alternative nucleophiles.Encouraged by these analyses with the
alkyne-β-lactone, we began examination of a diverse panel of β-lactone structures. Compounds
2−5 were added to holo-ACP2 and -3 as well as KS-AT6 at 10- and 50-fold excess and allowed 1h
of incubation, followed by proteolysis and LC-MS analyses. Acylation efficiencies, calculated as
percent loading, were obtained from peak heights of acylated peptides divided by the total
peptide (acylated plus unreacted) peak heights for a given LC-MS run (Table 1).
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Table 1. Loading of ACP2, ACP3, and KS-AT6 with β-lactone

loading, %
compd equiv of lactone ACP2 ACP3 KSAT6
1

2

3

4

5

10

33

55

7

50

93

97

64

10

78

64

26

50

97

97

65

10

53

62

41

50

96

94

62

10

8

13

6

50

32

36

14

10

7

15

27

50

28

35

58

The series of β-lactones tested with the ACP and KS showed different levels of acylation
but an interesting trend emerges from this study. The monosubstituted, alkyl-lactones,
compounds 1−3, are quite reactive toward both ACPs tested. In contrast, the disubstituted
lactone, compound 5, shows little ACP-acylation activity even at 50 equiv. KS-AT6, on the other
hand, is more reactive than ACP2 and -3 toward compound 5 but significantly less reactive with
compounds 1−3 than the ACPs. Finally, the monosubstitued, aromatic lactone, compound 4,
reacts sluggishly with both ACP and KS. These data offer promising preliminary evidence that βlactones can provide an efficient and selective means of acylating carrier proteins. High excess
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of lactones required for ACP-saturation was a primary concern. We wanted to address this issue
to improve the performance but given the limited scope of refining the structure of β-lactones
to improve reactivity, we looked towards other suitable electrophilic partners for ACP thiols.

2.2 Experimenatal details

5-hexynal : 20 mL of anhydrous dichloromethane (DCM) were cooled in a dry-ice/acetone bath
and oxalyl chloride (13.0 mmol) was added by syringe and stirred for several minutes. DMSO
(13.0 mmol) with10% v/v DCM was added dropwise by syringe. After gas evolution ceased, the
mixture was stirred for five minutes then 5-hexyn-1-ol (5.20 mmol) was added by syringe and
stirred for five minutes.
Triethylamine (26.01 mmol) was added by syringe and the mixture stirred for 15 minutes and
warmed to RT. The product was washed with 0.5 M HCl and ½ saturated NaHCO3, and dried over
MgSO4. The product was purified by flash chromatography over silica gel using 9:1
Hexanes:EtOAc mobile phase. 5-hexynal: 0.4200 g, 4.37 mmol of product, 84%, colorless oil.
1

H NMR (400 MHz, CDCl3) δ: 9.811 (s, 1H), 2.619 (t, J = 7.05 Hz, 2H), 2.278 (dt, J = 6.70 Hz, 2.45

Hz,2H), 1.999 (t, J = 2.38 Hz, 1H), 1.858 (quint J = 7.00 Hz, 2H)
13

C NMR (100 MHz, CDCl3) δ: 201.719, 83.188, 69.386, 42.530, 20.809, 17.772

General procedure 1: aluminum-catalyzed generation of β-lactones from aldehydes and acid
chlorides15.
A suspension of anhydrous AlCl3 (0.1 eq) and AgSbF6 (0.3 eq) in DCM cooled to -60°C in an
ethanol/ethylene glycol/dry ice bath, was added by syringe: N,N’-diisopropylethylamine (DIEA)
(1.5 eq), acid chloride (1.5 eq) and aldehyde (1 eq). The mixture was stirred for five hours at -
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60°C then filtered through a silica plug. Then product was purified by flash chromatography over
silica gel with a hexanes:ethyl acetate mobile phase.
General procedure 2: Nucleophile-catalyzed production of β-lactones from aldehydes and acid
Chlorides 16
For some reactions DABCO was substituted for the quinine catalyst, owing to the similar nature
of the nucleophillic substituent.
To a solution of trimethylsilyl quinine (TMSq3) (0.1 eq) or (DABCO) (0.2 eq) and LiClO4 (1.0 eq) in
30 mL of DCM and 10 mL of Et2O cooled to -78°C in a dry ice-acetone bath, was added via
syringe DIEA (3.0 eq), and aldehyde (1 eq). Acid chloride (1 - 2 eq diluted in DCM) was added
dropwise over ca. 3 hours. The mixture was stirred for 8 hrs at -78°C then diluted with an equal
volume of ether and allowed to come to room temperature. The mixture was filtered through a
silica plug then purified by flash chromatography over silica gel with a hexanes:ethyl acetate
mobile phase.
4-(pent-4-yn-1-yl)oxetan-2-one (1): General Procedure 1: AlCl3 (0.0427 mmol), AgSbF6 (0.1281
mmol), acetyl chloride (0.5976 mmol), DIEA (0.6656 mmol), 5-hexynal (0.4300 mmol). 3: 0.2389
mmol (56%), pale yellow oil.
1

H NMR (400 MHz, CDCl3) δ: 4.567 – 4.539 (m, 1H), 3.529 (dd, J = 16.76 Hz, 1.76 Hz, 1H), 3.129

(dd, J = 16.29 Hz, 1.67, Hz, 1H), 2.286 (dt, J = 6.61 Hz, 1.46 Hz, 2H), 2.001 (t, J = 2.4, 1H), 1.720 –
1.644 (m, 4H).
13

C NMR (100 MHz, CDCl3) δ: 168.101, 83.236, 70.785, 69.355, 43.029, 33.590, 23.867, 17.982.

Hi-res FAB MS calculated m/z for C8H11O2 [M+H]+ = 139.075356. Observed m/z = 139.0766.
4-propyloxetan-2-one (3): General Procedure 1: AlCl3 (0.99 mmol), AgSbF6 (2.9 mmol), acetyl
chloride (11 mmol), DIEA (11), butanal (9.8 mmol). 2: 8.134 mmol (83%), colorless oil.
1

H NMR (400 MHz, CDCl3) δ: 4.530 (dt, J = 2.96 Hz, 5.76 Hz, 1H), 3.522 (dd, J = 16.31 Hz, 5.78 Hz,
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1H), 3.067 (dd, J = 16.29 Hz, 4.28 Hz), 1.1.871 – 1.838 (m, 1H), 1.833 – 1.745 (m, 1H), 1.56 – 1.36
(m, 1H), 0.986 (t, J = 7.40 Hz)
13

C NMR (100 MHz, CDCl3) δ: 166.477, 69.238, 41.036, 34.826, 16.429, 11.802

4-(4-nitrophenyl)oxetan-2-one (4): General Procedure 2: DABCO (0.6 mmol), DIEA (9 mmol),
LiClO4 (3 mmol), p-nitrobenzaldehyde (3.0 mmol), acetyl chloride (3.0 mmol). N: 1.35 mmol
(45%), pale yellow oil.
1

H NMR (400 MHz, CDCl3) δ: 8.30 (d, J = 8.88, 2H), 7.60 (d, J = 8.46 Hz, 2H), 5.63 (dd, J = 6.3 Hz, J

=4.5 Hz, 1H), 4.04 (dd, J = 16.4, J= 6.3, 1H), 3.44 (dd, J = 16.5, J = 4.5, 1H)
13

C NMR (100 MHz, CDCl3) δ: 166.51, 148.42, 144.40, 126.50, 124.36, 69.51, 46.90

3-methyl-4-propyloxetan-2-one (5): General Procedure 2: TMSq (0.3 mmol), DIEA (7.5 mmol),
LiClO4 (3.0 mmol), butyraldehyde (3.0 mmol), propionyl chloride (3.0 mmol). N: 1.68 mmol
(56%), colorless oil.
1

H NMR (400 MHz, CDCl3) δ: 4.60 – 4.55 (m, 1H), 3.79 – 3.17 (m, 1H), 1.80 – 1.69 (m, 1H), 1.68 –

1.61 (m, 1H), 1.59 – 1.49 (m, 1H), 1.47 – 1.38 (m, 1H), 1.28 (d, J = 7.8 Hz, 1H), 1.00 (t, J = 7.4 Hz,
1H)
13

C NMR (100 MHz, CDCl3) δ: 172.86, 75.56, 47.22, 32.00, 18.79, 13.79, 8.06

Sulforhodamine-B Azide (SrB-A): 3-azido-1-aminopropane18 (0.22 mmol) and triethylamine (0.5
mmol) was dissolved in 1 mL of 5:1DCM:DMF and cooled to 0°C in an ice-water bath.
Sulforhodamine B sulfonyl chloride [mixture of ortho- and para- sulfonyl chloride isomers] (0.20
mmol) was added portion-wise over ca 30 min and stirred overnight at room temperature. The
product was purified by flash chromatography over silica gel with 90:5:5 DCM : acetonitrile :
methanol mobile phase. The ortho isomer was distinguished by its reversible color change in in
pH 9.0 buffer19. Para isomer (SrB-pA): 17%, ortho isomer (SrB-oA) 14%. Srb-oA was found to
perform best in the click reaction and was utilized for labeling experiments.
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NMR spectra are of poor quality due to long relaxation times. Product is pure by LC-MS.
Hi-res FAB MS calculated m/z for C30H37N6O6S2 [M+H]+ = 641.221049. Observed m/z = 641.2216.
3. Plasmid Construction
pCAD01 was prepared from an E. coli optimized synthetic construct (DNA2.0, Menlo Park, CA).
The synthetic gene was excised from the shipping vector via flanking NdeI and NotI restriction
sites and ligated into pET21b.
4. Protein Expression and Purification
SpnB was expressed from pCAD01. KSAT3 and KSAT6 were expressed from pAYC02 and
pAYC1120respectively. ACP2 was expressed from pNW621, ACP3 was expressed from pVYA0522.
Apo SpnB and ACPs were expressed in E. coli BL-21 cells and Holo SpnB and ACPs were
expressed in E.Coli BAP-123. pCAD01, pAYC02, and pAYC11 contain ampicillin resistance vectors,
pNW6 and pVYA05 contain kanamycin resistance vectors.
General Procedure for Protein Expression and Isolation
Bacteria were grown in 1 L shake cultures of LB-antibiotic media at 37°C in a New Brunswick
Scientific Excella E24 Incubator Shaker until the OD600 was between 0.6 and 0.8.
Overexpression was induced with 200 μL of 1 M IPTG and carried out at 18°C for 18 hours, after
this point all work was carried out at 4°C. Cells were pelleted by spinning at 3000 RPM for 10
minutes in a Sorvall RC6 Plus with a FiberLite F21S-8x50 rotor and resuspended in 50 mL of lysis
buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium Na3VO4, 1 μg/mL leupeptin, pH 7.5).
Cells were lysed using a Misonics ultrasonic converter without microtip, amplitude 30 for five 30
second intervals with a 60 second cool down period between each. Lysed cells were spun at
10,000 rpm and with a FiberLite F10S5 6x500 Y rotor for 60 minutes. The lysate was equilibrated
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with 3 mL of PerfectPro Ni-NTA bead slurry for 60 minutes by stirring with a PTFE-coated stir bar
at 60 RPM for 60 minutes. The lysate was then poured into a 15 mL column and the supernatant
eluted. The column was then washed with two 15 mL portions of wash buffer (50 mM
phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0), and eluted with 3 mL of elution buffer (50
mM phosphate, 300 mM NaCl, 250 mM imidazole, pH 8.0). The purified protein was loaded into
an Amicon Ultra centrifugal concentrator and diluted to 15 mL with storage buffer (100 mM Tris,
1 mM EDTA, 1 mM dithioerythritol, 10% glycerol pH 8) and spun at 3000 rpm in Eppendorf
Centrifuge 5810 R with swinging-bucket rotor. Dilution and filtration was repeated a total of
three times. Protein concentration determined by Bradford assay, average concentration was
approximately 500 μM. Proteins were flash frozen and stored at -80°C until use.
5. Loading Proteins with β-lactones
Labeling reactions for gel assays were performed at 20 μL total volume, reactions for LC-MS
were performed at 50 μL total volume. Final concentrations reported in procedure.
Loading ACPs
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and protein (0.025
mM) were reacted at ambient temperature for 15 min. Then β-Lactone was added to the
appropriate concentration (1, 5, 10, 20, 50, or 75x with respect to protein for saturation
experiments, 10 or 50x with respect to protein for loading experiments) and the mixture reacted
at ambient temperature for 60 min.
Loading KSATs
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and KSAT (0.025
mM) were reacted at ambient temperature for 15 min, then β-Lactone (2.5 mM) was added (1,
5, 10, 20, 50, or 75x with respect to protein for saturation experiments, 10 or 50x with respect
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to protein for loading experiments) and the mixture incubated at ambient temperature for 60
min.
Loading SpnB
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and SpnB (0.015
mM) were reacted at ambient temperature for 15 min, then β-Lactone was added (10, 50, or
75x with respect to protein) and the mixture incubated at ambient temperature for 60 min.
Acyl Transfer
Phosphate buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (2.5 mM), and ACP (0.025 mM)
were reacted at ambient temperature for 15 min. Then β-Lactone (10 equivalents) was added
and the mixture reacted at ambient temperature for 60 min. Then KSAT was added and the
mixture incubated at ambient temperature for 60 min.
6. Chromophore Attachment
The reaction was carried out at 25 μL, final concentrations reported. SrB-oA, (2x alkyne
concentration), sodium ascorbate (1 mM), and copper (II) sulfate (1 mM) were added to samples
which had been labeled with 1. The reaction was performed at ambient temperature for 60
minutes.
7. Gel Assay
Labeled samples were diluted to 35 μL with gel-loading buffer. ACPs and KSATs were
separated by 12.5% SDS-PAGE with 5% stacking gel (100 V, 50 mA, 135 min). SpnB was
separated by 4 – 20% gradient HEPES-PAGE (100 V, 50 mA, 90 min). Gels were developed in 10%
acetic acid to visualize Srb-oA. Srb-oA labeled proteins were imaged on a BioDoc-It Imaging
System with UVtransilluminator. Total protein was stained using GelCode Blue.
8. Proteolysis
Promega Sequencing Grade Modified Trypsin was added to prepared samples so that the final

33

trypsin:ACP ratio was 1:50 (w/w). The mixture was incubated at 30°C for 18 hours. Digestion was
quenched by addition of an equal volume of 10% formic acid. Digests were flash frozen in N2(l)
and stored at -20°C until analysis.
9. LC-MS
Separation was performed with a Waters 1525 system. The gradient employed was A = water +
0.1% formic acid, B = acetonitrile + 0.1% formic acid, 5-95% B over 60 min with a Vydac 218TP
C18 5u column (4.6 x 150 mm). Mass spectra were acquired with a Waters Micromass ZQ mass
detector in EI+ mode: Capillary voltage = 3.50 kV, cone voltage = 30 V, extractor = 3 V, RF lens =
0.0 V, source temp = 100°C, desolvation temp = 200°C, desolvation gas = 300 L/hr, desolvation
gas = 0.0 L/hr The system was operated and spectra were processed using the Waters Empower
software suite.
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CHAPTER 3
β-LACTAMS AS VERSATILE REAGENTS FOR ACYL CARRIER PROTEIN LABELING

3.1 Introduction

As introduced in the previous chapter, we began with a simple idea of using electrophilic
β-lactones as acylating agents for ACPs.1 Our hypothesis was that the resulting ACP-bound βhydroxythioester would represent a common structural motif in modular polyketide
biosynthesis . A panel of the substituted lactones was examined for selectivity for the Ppantthiol over competing nucleophiles, including the KS active site. All of the lactones investigated
showed some level of Ppant-acylation ,monosubstituted β-lactones were generally both more
reactive and selective. However, it emerged that even the best acylating agents required a very
large excess to obtain saturation of the ACPs, indicating that the reactivity of lactones needed
improvement. With limited scope of structural modifications given the lactone structure, we
were compelled to consider alternate electrophiles for future experimentation. With the
purpose of improving upon the reactivity of β-lactones, we explored the idea of using β-lactams
as electrophilic parners for ACPs. A series of N-activated β-lactams were prepared to examine
site-specific acylation of the phosphopantetheine-thiol.
An initial concern was that increased reactivity may result in higher off-target
interactions with competing nucleophiles, such as the KS-active site, and decreased selectivity
for the targeted Ppant group. To circumvent competition from other nucleophiles for initial
experimentation, we adapted the use of separated stand-alone domains of ACP and KS-AT2-5, as
introduced and discussed in Chapter 1. The separated domains retain their function when
reintroduced in vitro. As a result, the challenge of designing Ppant-acylating agents is reduced to
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one of selectivity for holo-ACP over apo-ACP alone since the KS domain can be introduced after
ACP-loading has occurred without limiting the scope of its utility.
In this manner, by using separated domains, we began to explore β-lactams as thiol reactive acylating agents for isolated ACP domains. Relative to β-lactones, the amide nitrogen of
β-lactams offers an additional site for ring substitution that is electronically coupled to the
carbonyl, thus providing a reliable means of tuning electrophilicity. The experimental set-up
descrbed here is used to establish N-activated β-lactams as efficient and versatile acylating
agents for ACP domains. Further along, we wished to increase our understanding of KS-ACP
recognition and intermodular polyketide transfer between these components, for which,
fluorescence and affinity labeling applications were designed.

3.2 Results and discussion

Figure 13. N-activated β-lactams
β-lactams were employed as electrophilic partners as they were expected to have a
reactive advantage relative to β-lactones through appropriate activation of the ring nitrogen. 6
To test this hypothesis, a panel of diverse β-lactams were prepared by introducing common
nitrogen -protecting groups onto the parent azetidinone (compound 1) via established methods
to produce compounds 2–5 (Figure 13.)7-10.To establish the extent of acylation, saturation
curves were generated by varying the number of equivalents of each lactam relative to isolated
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holo-ACP2 (module 2) and holo-ACP3 (module 3) from 6-deoxyerythronolide B synthase (DEBS)
in analogous fashion to our previous work with β-lactones.1 In general, it was performed by
incubating the ACP with the lactam for 1 h at room temperature. The mixture was subjected to
trypsin digestion and subsequently quenched with formic acid. The resulting array of peptide
fragments was analyzed by LC-MS (Figure 14). The extent of loading was estimated from the
ratio of acylated Ppant-containing peptide to total Ppant-containing peptide , assuming similar
ionization potentials. Acylation experiments showed that compounds 2–5 exhibited excellent
acylation efficiencies with both holo-ACPs(Table 2,3). All compounds, with exception of Bocactivated lactam(compound 5), showed around 80% loading at a low 10 equivalents (Figure 14.).
To demonstrate the benefit of using lactams, a direct competition between compound 6 and the
most reactive β-lactone from our previous study, 4-methyloxetan-2-one was performed by
treating ACP2 simultaneously with 10 equivalents of each for 1 h. The acylated-ACP was
trypsinized and the resulting peptide fragments were analyzed by LC-MS which clearly
demonstrates a reactive advantage of β-lactams for acylation of holo-ACP (Figure 15.). Again, in

ACP2

ACP3

Figure 14. Saturation curves for β-lactam loading
Determined by tandem proteolysis-mass spectrometry for ACP2 (Top) and ACP3 (Bottom) with
compounds 2-6. Equivalents of lactam are per protein molecule. Lines are added for clarity.
Error bars represent one standard deviation (n=3).
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Figure 15. β-lactams vs. β-lactone ACP-acylation
the absence of any solvent-exposed cysteine residues, the Ppant-thiol is the only competent
nucleophile present as these ACP.
Table 2. ACP2 loading with β-lactams
Compound 2
Equivalents

Compound 3

Compound 4

St.
Avg.

St. Dev

Avg.

St. Dev

Avg.

Dev
0.5

12.3

15.0

18.9

2.7

15.3

9.3

12.0

13.9

1.9

11.6

27.0

29.0

23.0

2.5

26.4

1.0

50.2

54.2

56.1

2.4

53.3

21.1

23.7

24.3

1.4

22.8

47.2

51.8

44.0

2.5

47.8

5.0

78.5

79.9

85.6

2.9

81.6

82.3

85.4

89.0

2.7

85.0

73.5

68.0

76.9

3.2

72.8

10.0

80.5

83.4

89.6

3.8

84.5

84.4

92.0

93.0

3.8

90.0

82.0

85.4

78.0

3.0

81.9

20.0

84.5

92.4

93.0

3.9

89.9

90.4

95.4

96.4

2.7

94.0

88.1

90.0

94.7

2.7

91.0

50.0

92.0

93.6

96.5

1.9

94.0

94.5

98.7

99.5

2.2

97.5

92.0

98.4

98.0

2.9

96.1

St. Dev

Avg.

Compound 5
Equivalents

Compound 6
St.
Avg.
Dev

0.5

2.1

2.9

4.8

1.1

3.3

10.4

12.0

13.4

1.2

11.9

1.0

7.5

8.9

11.1

1.4

9.2

26.0

29.0

30.6

1.9

28.5

5.0

9.8

15.3

15.8

2.7

13.7

65.2

69.0

72.9

3.1

69.0

10.0

36.7

39.8

45.9

3.9

40.8

91.1

94.9

96.0

2.1

94.0

20.0

68.7

70.4

76.3

3.2

71.7

96.2

98.9

99.5

1.5

98.3

50.0

98.4

97.8

93.1

2.8

96.6

96.8

98.9

99.8

2.4

98.6
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Table 3. ACP3 loading with β-lactams
Compound 2

Compound 3

Equivalents

St. Dev

Avg.

Compound 4
St. Dev

Avg.

St. Dev

Avg.

0.5

41.6

39.8

42.9

1.2

41.9

18.6

21.0

22.5

1.6

20.7

18.0

16.5

13.0

2.1

15.8

1.0

58.0

59.9

56.0

1.6

57.9

42.1

43.7

44.4

1.0

43.3

38.0

41.0

36.0

2.1

38.2

5.0

62.5

64.6

66.2

1.5

64.4

52.5

55.8

56.9

1.9

55.1

46.0

44.0

45.8

0.9

45.2

10.0

73.1

77.4

84.3

4.6

78.3

78.0

85.8

86.2

3.8

83.2

76.0

71.0

80.0

3.7

75.6

20.0

80.2

81.9

83.7

1.4

82.0

89.9

89.7

95.7

2.8

91.8

85.0

79.0

89.0

4.1

84.4

50.0

81.4

85.8

88.3

2.9

85.0

94.8

98.9

99.4

2.4

98.1

27.0

29.0

23.0

3.7

94.7

St. Dev

Avg.

Compound 5

Compound 6

Equivalents

St. Dev

Avg.

0.5

5.2

6.0

7.2

0.8

6.0

11.4

12.1

14.2

1.2

12.5

1.0

14.0

13.4

16.0

1.1

14.5

28.6

32.0

33.1

1.9

31.1

5.0

24.5

28.0

30.2

2.3

27.6

75.6

81.2

83.1

3.1

79.4

10.0

55.0

61.0

68.4

5.5

61.4

83.1

86.9

87.9

2.1

85.8

20.0

67.5

72.9

74.1

2.9

71.4

89.4

92.0

93.2

1.5

91.6

50.0

89.4

94.3

98.0

3.5

93.9

90

94

95.6

2.4

93.4

A gel-based fluorescent assay was used, based on work by Sieber and coworkers, to
further amine selectivity for holo- over apo-ACP11. A [3 + 2] cycloaddition (click reaction) was
used for coupling acylated ACPs to a rhodamine-based fluorophore.12–14 ACP2 and ACP3 (both
holo and apo) were mixed with 1, 5, and 10 equivalents of 6 and reaction continued at room
temperature for 1 h. The click step was performed with addition of Rhodamine azide along with
all necessary click reaction components and the resulting protein products were analyzed via
SDS-PAGE . Bright bands were observed for the holo-ACPs while apo-ACPs provided only
background fluorescence (Figure 16.). Remarkably, fluorescence can be easily observed at an
impressive 5 equivalents of lactam for both ACPs, indicating the extent of reactivity.
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Figure 16. Fluorescence SDS-PAGE analysis of DEBS ACP2 and ACP3
In order to explore Ppant selectivity and further demonstrate utility of the alkyne
handle, we turned our focus to mixtures of apo and holo ACP2. We wanted to test whether
holo-ACP2 could be isolated from a mixture of apo and holo by an affinity label conjugated to
compound 6. A biotin -streptavidin interaction was used as on bio-orthagonal agent for ACP
purification as this system (1) has been used extensively for protein separations15–18 and (2)
relies on a small molecule that we envisioned could readily be conjugated to the lactam
warhead. As proof of principle and to assess the efficiency of each step, we began with samples
of pure holo-ACP. Initially, attempts to pre-conjugate compound 6 with the biotin azide followed
by 1 h reaction with the ACP resulted in low yields of the acylated protein . Another observation
was competition from other proteinaceous nucleophiles for longer reaction times which forced
us to consider an alternative order of addition.
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Figure 17. Whole protein mass spectra of ACP2 purification strategy
(top) an initial 80:20 (holo:apo) mixture of ACP2 and (bottom) the result of β-lactam based
purification of holo-ACP2. The lack of apo-ACP2 in the latter indicates that the β-lactam
(compound 6) is highly selective for holo-ACP2
The [3 + 2] cycloaddition of the biotin azide with pre-acylated holo-ACP resulted in 30%
recovery following streptavidin–sepharose binding and subsequent treatment of the bound
material with hydrazine, which restores the Ppant-thiol via nucleophilic attack on the thioester
carbonyl. However, the samples has to be subjected to filtration twice prior to treatment with
the streptavidin beads, to remove excess lactam and biotin following the initial acylation and
subsequent [3 + 2] cycloaddition. The protein concentration was analyzed at each stage which
revealed that the primary source of ACP loss in the process was these filtration steps. In fact,
more than 60% of the protein subjected to the streptavidin was recovered upon treatment with
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hydrazine while almost half of the initial mixture is lost to the filtration membrane before this
step. It is expected that upon scale-up, where small losses of protein to filtration are less
significant, percent recovery will be drastically improved. As proof of principle, however, we
were confident that these recovery levels would suffice for further experimentation.
The holo (Ppantylated)-form of ACP is resulted due to overexpression of ACP in BAP1,
an engineered strain of E. coli with a phosphopantetheinyl transferase embedded in the
genome. However, as expression levels increase, the transferase performance suffers resulting
in mixtures of holo- and apo-ACP. We examined the viability of our approach for separating
holo- from apo-ACP with a 80 : 20 (holo : apo) mixture of ACP2, a typical ratio observed from
overexpression of ACP in BAP1, and subjected it to the same process described above. Analysis
of the final solution obtained from hydrazine treatment of the bound material by LC-MS
revealed only holo-ACP2 (Figure 17.). Taken together with the fluorescence assay, these
experiments nicely illustrate the remarkable Ppant-selectivity and versatility of compound 6.
We wanted to confirm that the purification process did not alter the protein structure. It
was confirmed by examining the ability of eluted holo-ACP2 to accept a methylmalonyl-CoA unit
from an acyltransferase. Methylmalonyl-CoA and purified holo-ACP was added to a buffered
solution of DEBS module 6 ketosynthase-acyltransferase didomain5,19-21 ([KS6AT6]). After 30 min
of reaction time, the mixture was subjected to trypsinolysis and the resulting peptide fragments
were separated and analyzed via LC-MS (Figure 18.). The prominent peak at 809.1 mass units
suggests that the purified ACP remains competent for AT-ACP methylmalonate transfer as seen
previously.21
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Figure 18. Mass spectrum of methylmalonyl-CoA transfer to purified ACP
In this manner, it was established that carrier proteins could be efficiently acylated with
β-lactams. However, to demonstrate the utility of these reagents for PKS examination, a direct
comparison to traditional small molecule probes was necessary. In particular, we were
interested in ACP to KS transfer of the β-aminothioester product (Figure 19.). Polyketide
intermediate transfer between ACP and KS plays a critical role in product generation for all PKS
systems and acts as a primary determinant for proper flow of intermediates during polyketide
biosynthesis. As discussed in Chapter1, N-acetylcysteamine thioester (SNAc) mimics the terminal
portion of the Ppant group and is most commonly used for direct acylation of KS active sites.22–25
A gel-based fluorescence assay was employed to qualitatively determine the kinetic competency
of our lactam -derived acyl-ACPs, relative to propionyl-SNAc and the potent KS-inhibitor,
cerulenin26.

Acylation of holo-ACP2 was executed as before using 10 equivalents of compound 6
followed by Cu-mediated [3 + 2] cycloaddition with rhodamine azide. The resulting acyl-ACP was
incubated with [KS6AT6] for 1 h at room temperature with or without competing KSacylating/alkylating agents to explore ACP to KS transfer (Figure 20.). From these data , it is clear
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Figure 19. Schematic for fluoroscence assay for ACP to KS acyl transfer.
that fluorescence transfers from the ACP to KS in the absence and presence of both cerulenin
and propionyl-SNAc, indicating that the lactam -derived acyl-ACPs are, at a minimum,
competitive with traditional small molecule probes (Lanes 2, 4, and 6). The lack of KSfluorescence observed when [KS6AT6] is pre-treated with each competitor (Lanes 3 and 5)
confirms that transfer is occurring between the Ppant arm and KS active site. Finally, the
absence of a fluorescent band when [KS6AT6] is treated directly with the compound 6rhodamine click product implies that the ACP is required for transfer to occur (Lane 7). In all,
these results suggest that β-lactam-derived, acyl-ACPs behave in analogous fashion to natural
polyketide intermediates and are kinetically competitive with traditional PKS probes and
inhibitors . Further experimentation to quantitatively determine the transfer rate is currently
ongoing in the lab but, at this point, it is clear that activated β-lactams offer a greatly simplified
and readily adaptable set of carrier protein modifiers.
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3.3 Conclusion
In summary, we have demonstrated the utility of N-activated β-lactams for acylation of
holo-ACPs. The structures examined are significantly more reactive than the β-lactones that we
have previously reported and all are available in a single synthetic step from commercially
available starting materials. Both carbamate and sulfamate moieties effectively activate the
lactam ring for ACP-acylation. The resulting acylation products maintain the thioester linkage
common to all polyketide biosynthetic intermediates and the reaction can be readily reversed
by treatment with hydrazine.
The applications of β-lactams demonstrated so far just begin to scratch the surface of
their capabilities. The N-propargyloxycarbonyl group (compound 6) provides a versatile chemical
handle for nearly limitless elaboration of structure. Although we have focused exclusively on
proteins involved in polyketide biosynthesis , we expect the general thiol -reactivity of these
simple β-lactams to translate well to other systems bearing natural or engineered thiols.
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Figure 20. Fluorescent competition assay for ACP to KS acyl transfer.
(Top) Fluorescent ACP2 (ACP*) is prepared via click coupling of rhodamine azide with
ACP2, preacylated with compound 6. ACP2* is then incubated with [KS6AT6] under
various conditions. Lanes are marked with the corresponding components for each
1

reaction. [KS6AT6] was mixed with competitor (cerulenin or propionyl-SNAc) for 1 hour
2

prior to addition of ACP* (Lanes 3 and 5). ACP* and competitor were introduced to
3

[KS6AT6] simultaneously (Lanes 4 and 6). [KS6AT6] was mixed with 10 eq of the click
product in the absence of ACP2 (Lane 7). SNAc = N-acetylcysteimine. (Bottom) PAGE full
gel stain.

48

3.4 Experimental Details

Synthesis
1-[(4-Methylphenyl)sulfonyl]azetidin-2-one27 (2). 2-Azetidinone (72 mg, 1 mmol) was dissolved
in THF (5 mL) at −78 °C. NaHDMS (367 mg, 2 mmol) dissolved in THF (1 mL) was added in
portions. 4-Toluenesulfonyl chloride (763 mg, 4 mmol) dissolved in THF (5 mL) was added to the
reaction mixture in portions slowly over 15 min. The reaction mixture was stirred until all the
starting material was consumed (monitored by TLC ), approximately 8 h. The reaction was
washed with sodium bicarbonate (10 ml ×3) and extracted with DCM (25 mL ×3). The combined
organic layers were dried over Na2SO4, and the solvent was removed by rotary evaporation . The
crude material was purified by flash chromatography with 1 : 1 hexane : ethyl acetate. Yield:
(178 mg, 0.79 mmol) 79% of final product as colorless solid.
1

H NMR (400 MHz, CDCl3) δ: 7.9–7.87 (d, J = 8.29, 2H), 7.32–7.41 (d, J = 8.48, 2H), 3.67–3.64 (t, J

= 5.2, 2H), 3.06–3.02 (t, J = 5.1, 2H), 2.46 (s, 3H).13C NMR (400 MHz, CDCl3) δ: 161.9, 143.4,
128.3, 125.7, 38.0, 34.9, 19.9. IR : ν 2973, 1776, 1362, 1154, 682, 98 cm−1, MS [M + H]+ = 227
Benzyl 2-oxoazetidine-1-carboxylate8 (3). HDMS (250 mg, 1.5 mmol) was dissolved in THF (8
mL) and cooled to −78 °C. nBuLi (96 mg, 1.5 mmol) was added dropwise and stirred for 30 min.
In a separate RBF, 2-azetidinone (106.6 mg, 1.5 mmol) was dissolved in 5 mL of THF at −78 °C.
The contents of the first flask were transferred via cannula to the second flask and stirred for 1
h. Benzylchloroformate (256 mg, 1.5 mmol) was added in portions and stirred for 2 h at −78 °C.
The reaction mixture was allowed to warm to ambient temperature and stirred for an additional
4 h. The reaction mixture was diluted with water and extracted with DCM (50 mL × 3).
Combined organic phases were washed with brine and dried over Na2SO4. Solvent was removed
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by rotary evaporation . Purification of crude product by flash chromatography with 5 : 1 hexane
: ethyl acetate yields (285 mg, 1.39 mmol) 93% of product as an oil.
1

H NMR (400 MHz, CDCl3) δ: 7.28–7.16 (m, 5H), 5.1 (s, 2H), 3.44–3.4 (t, J = 5.3, 2H), 2.85–2.81(t, J

= 5.3, 2H).13C NMR (400 MHz, CDCl3) δ 23.7, 34.7, 36.1, 65.9, 126.1, 126.8, 147.1, 155.0, 167.8.
IR : ν 3040, 2985, 1811, 1724, 1388, 1330, 1214, 1177, 1120, 1044, 763, 699 cm−1, MS [M + H]+ =
206
(9H-Fluoren-9-yl)methyl 2-oxoazetidin-1-carboxylate (4). 2-Azetidinone (72 mg, 1 mmol) was
dissolved in THF (5 mL), and LiHDMS (167 mg, 1 mmol) dissolved in THF (2 mL) was added
dropwise at −78 °C over a 15 min period and stirred for an additional 30 min. 9-Fluorenylmethyl
chloroformate (259 mg, 1 mmol) dissolved in THF (2 mL) was added dropwise at −78 °C. The
resulting mixture was stirred for 1 h at −78 °C, then allowed to warm to R.T, and stirred for 1 h
further at which point the starting material had been completely consumed (monitored by TLC ).
The reaction mixture was poured into water and extracted with DCM (3 × 25 mL). The combined
extracts were washed with brine and dried over Na2SO4. After removal of the solvent by rotary
evaporation , the crude reaction mixture was purified by flash chromatography with DCM : ethyl
acetate, 95 : 5, producing the product as an off-white solid (62 mg, 0.62 mmol) in 86% yield.
1

H NMR (400 MHz, CDCl3) δ 3.13 (t, 2H), 3.68 (t, 2H), 4.32 (t, 1H), 4.47 (d, 2H), 7.26–7.80 (m, 8H).

13

C NMR (400 MHz, CDCl3) δ 162.1, 148.3, 141.3, 139.4, 126.4, 125.5, 123.5, 118.1, 66.8, 44.3,

34.8, 36.2. IR : ν 3015, 2922,1770, 1722, 1449, 1388, 1313,1119, 1044, 964, 738 cm−1. HRMS (EI+)
Calcd for C18H15NO3, 293.1052; Found, 293.1046
tert-Butyl 2-oxoazetidine-1-carboxylate28 (5). 2-Azetidinone (72 mg, 1 mmol) and DMAP (12.2
mg, 0.1 mmol) were dissolved in acetonitrile (5 mL) at 0 °C. Di-tert-butyl dicarbonate (218 mg,
1.1 mmol) was added to the reaction mixture in portions. The reaction mixture was stirred at 0
°C for 2 h, allowed to warm to ambient temperature and stirred overnight. The reaction mixture
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was diluted with ethyl acetate and washed with 1 N aq. HCl and brine. The aqueous layer was
extracted with ethyl acetate (25 mL ×3). Combined organic layers were dried over Na2SO4 and
the solvent was removed by rotary evaporation . The crude product was purified by flash
chromatography using 2 : 1, hexanes : ethyl acetate (154 mg, 0.9 mmol) 90% of product as an
oil.
1

H NMR (400 MHz, CDCl3) δ: 3.56–3.52 (t, J = 5.1, 2H), 3.03–2.87 (t, J = 5.2, 2H), 1.5 (s, 9H). 13C

NMR (400 MHz, CDCl3) δ: 205.4, 162.1, 146.5, 81.2, 36.8, 35.0, 29.8, 26.2. IR : ν 2984, 1795,
1719, 1331, 1157, 1043 cm−1, MS [M + H]+ = 172
Prop-2-yn-1-yl 2-oxoazetidine-1-carboxylate (6). 2-Azetidinone (107 mg, 1.5 mmol) was
dissolved in THF (7 mL) at −78 °C. LiHDMS (330 mg, 2 mmol) dissolved in THF (2 mL) was added
in portions over 10 min and the reaction mixture was stirred for 30 min. Propargyl
chloroformate (181 mg, 1.5 mmol) dissolved in THF (2 mL) was added in portions over 10 min
and the reaction mixture was stirred at −78 °C for 2 h then allowed to warm to ambient
temperature. The reaction mixture was diluted with water and extracted with DCM (50 mL ×3).
The combined organic layers were washed with brine and dried over Na2SO4. Solvent was
removed by rotary evaporation . Purification of crude product by flash chromatography with 95
: 5 DCM : methanol yields (106 mg, 0.69 mmol) 46% of product as a pale yellow solid.
1

H NMR (400 MHz, CDCl3) δ 4.82–4.81(d, J = 23.3, 1H), 3.68–3.65 (t, J = 5.3, 2H), 3.10–3.07 (t, J =

5.3, 2H), 2.55–2.53 (t, J = 2.4, 1H). 13C NMR (400 MHz, CDCl3) δ 34.9, 36.1, 51.8, 74.0, 146.3,
162.2. IR : ν 3251, 2925, 2134, 1782, 1722, 1313, 1187, 1114, 1045, 615 cm−1. HRMS (EI+) Calcd
for C7H7NO3, 153.0426; Found, 153.0402
Sulforhodamine-B azide (S1)1. 3-Azido-1-aminopropane29 (22 mg, 0.22 mmol) and triethylamine
(51 mg, 0.5 mmol) were dissolved in 1 mL of 5 : 1 DCM : DMF and cooled to 0 °C.
Sulforhodamine B, sulfonyl chloride [mixture of ortho- and para- sulfonyl chloride isomers] (115
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mg, 0.20 mmol) was added portion-wise over ca. 30 min and stirred overnight at room
temperature. Solvent was removed in vacuo, and the product was purified by flash
chromatography over silica gel with 90 : 5 : 5 DCM : acetonitrile : methanol mobile phase . The
ortho isomer was distinguished by its reversible color change in pH 9.0 buffer .30para Isomer: (22
mg 0.034 mmol) 17%, ortho isomer (18 mg, 0.028 mmol) 14%. Both obtained as a red solid with
a metallic green luster. The ortho isomer was found to perform best in the click reaction and
was utilized for labeling experiments.
NMR spectra are of poor quality due to long relaxation times. Product is pure by LC-MS . IR : ν
2975, 2100, 2590, 1339, 1180 cm−1 HRMS (EI+) Calcd for C30H37N6O6S2, 641.2210. Found,
641.2216.
Biotin azide (S2). D(+)-biotin (73 mg, 0.300 mmol) was dissolved in 3 mL of DMF by briefly
heating the mixture with a heat gun. The mixture was cooled to 0 °C in an ice-water bath and 6chloro-1-hexanol (120 mg, 0.900 mmol), and N,N-dimethylamino pyridine (73 mg, 0.600 mmol)
were added. N-(3-Dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (115 mg, 0.600
mmol) was added in portions over ca. 60 min and the reaction mixture was allowed to come to
room temperature. Stirring was continued for 24 h. When biotin had been consumed
(monitored by TLC ), the reaction mixture was diluted with ethyl acetate (100 mL). The organic
phase was washed with concentrated NaHCO3 (3 × 50 mL), and pH 2 saturated Na2SO4 (5 × 50
mL portions). Solvent was removed by rotary evaporation and the material was used without
further purification . The material from the ester coupling was dissolved in 5 mL of DMF and
NaN3 (40 mg, 0.600 mmol) and a catalytic amount of KI were added. A reflux condenser was
attached and the reaction mixture was heated to 80 °C for 16 h. The material was diluted with
100 mL of ethyl acetate and washed with brine. The solvent was removed by rotary evaporation
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and the crude material purified by flash chromatography (5% MeOH in DCM) to yield 67 mg,
0.182 mmol of product (61%) as a waxy pale yellow solid.
1

H NMR (400 MHz, CDCl3) δ (ppm) 1.32–1.52 (m, 6 H) 1.56–1.80 (m, 8 H) 2.33 (t, J = 7.45, 2 H)

2.74 (d, J = 12.76, 1 H) 2.91 (dd, J = 12.82, 4.99, 1 H) 3.16 (ddd, J = 8.34, 6.38, 4.74, 1 H) 3.28 (t, J
= 6.88, 2 H) 4.06 (t, J = 6.63, 2 H) 4.31 (ddd, J = 7.67, 4.71, 1.14, 1 H) 4.51 (dd, J = 7.71, 5.05, 1 H)
5.67 (s, 1 H) 6.03 (s, 1 H). 13C NMR (400 MHz, CDCl3) δ (ppm) 173.7, 163.7, 65.6, 61.2, 60.8, 56.1,
51.3, 40.5, 33.9, 29.9, 28.7, 28.4, 27.2, 26.3, 25.5, 24.8. IR : ν 3230, 2934, 2101, 1733,1700, 1264,
1175 cm−1HRMS (EI+) Calcd for C16H27N5O3S, 369.1848; Found, 369.1814
Propionyl-N-acetylcysteamine (Propionyl-SNAc) To a solution of triethylamine (2.80 mmol) in
dichlromethane (5 mL) was added propionic acid (1.40 mmol), (3-dimethylaminopropyl)-3ethylcarbodiimide hydrochloride (1.40 mmol), 1-hydroxybenzotriazole (HOBt) (1.40 mmol) and
N-acetyl cysteamine (SNAc)(1.35 mmol). The reaction mixture was stirred overnight. The organic
layer was washed with saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then
dried over anhydrous sodium sulfate, concentrated under vacuum, and purified by flash column
chromatography (1 : 1 hexane : ethyl acetate) to provide compound (140 mg, 74%) as a pale
yellow oil.
1

H NMR (400 MHz, CDCl3) δ (ppm) 0.86(t,J = 7.58 Hz, 3H) 1.69 (s, 3H) 2.28 (q, J = 7.4 Hz, 2H)

2.72(t, J = 6.8 Hz, 2H) 3.07 (q, J = 6.6 Hz, 2H) 7.39 (br s, 1H).13C NMR (400 MHz, CDCl3) δ (ppm)
199.4, 170.6, 39.0, 36.8, 28.0, 22.6, 9.4. IR : ν 3282,2979,1690,1650,1546,1373,1288,1090,935
cm−1MS [M + H]+ = 176
Protein expression and purification
ACP2 was expressed from pNW06,31 ACP3 was expressed from pVYA05.5 [KS6AT6] was
expressed from pAYC11.20apo-ACPs were harvested from E. coli BL-21 and holo-ACPs were
harvested from E. coli. BAP-132 pNW6 and pVYA05 contain kanamycin resistant vectors.
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General procedure for protein expression and isolation
Bacteria were grown in 1 L shake cultures of LB-antibiotic media at 37 °C in an incubating shaker
until the OD600 was between 0.6 and 0.8. Over expression was induced with 200 μL of 1 M IPTG
(per liter of culture) and carried out at 18 °C for 18 h. After this point all work was carried out at
4 °C. Cells were pelleted by spinning at 3000 RPM for 10 min and resuspended in 50 mL of lysis
buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium Na3VO4, 1 μg mL−1 leupeptin, pH 7.5).
Cells were lysed using an ultrasonic converter. The lysate was pelleted at 10,000 rpm for 60 min.
The supernatant was equilibrated with 3 mL of Ni-NTA slurry (per liter of culture) for 60 min by
stirring with a PTFE-coated stir bar at minimal speed. The mixture was then poured into a fritted
column and the supernatant eluted. The resin bed was washed with two 15 mL portions of wash
buffer (50 mM phosphate, 300 mM NaCl, 20 mM imidazole , pH 8.0), and eluted with 3 mL (per
liter of culture) of elution buffer (50 mM phosphate, 300 mM NaCl, 250 mM imidazole , pH 8.0).
The purified protein was loaded into a 3 kDa NMW centrifugal concentrator and diluted to 15
mL with storage buffer (100 mM Tris, 1 mM EDTA, 1 mM dithioerythritol, 10% glycerol pH 8) and
spun until the final volume was ≤500 μL. Dilution and filtration was repeated a total of three
times. Protein concentration was determined by Bradford assay with a BSA standard curve,
average final concentration was approximately 3 mM. Proteins were flash frozen and stored at
−80 °C until use.
Proteins acylation with β-lactams
Labeling reactions for gel assays were performed at 20 μL total volume, reactions for LC-MS
were performed at 50 μL total volume. Final concentrations reported in procedure. Phosphate
buffer (100 mM, pH 7), tris(2-carboxyethyl)phosphine (TCEP) (2.5 mM), and protein (0.025 mM)
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were reacted at ambient temperature for 15 min. β-Lactam was added to achieve the
appropriate final concentration (0.5, 1, 5, 10, 20, 50x) with respect to protein . The mixture was
equilibrated at ambient temperature for 60 min.
β-Lactam/β-lactone competition loading of ACP
10 equivalents of compound 6 and 4-methyloxetan-2-one were mixed and introduced to
buffered holo-ACP2 for 1 h. The sample was trypsinized analyzed by LC-MS as described
previously.1
Chromophore attachment
The reaction was carried out at 25 μL, final concentrations reported. S1, (2× with respect to 6),
sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added to samples which had been
labeled with 6. The reaction was performed at ambient temperature for 60 min.
Gel assay
Labeled samples were diluted to 35 μL with gel-loading buffer . ACP 2 was separated by 12% and
ACP 3 with 15% SDS-PAGE , each with a 5% stacking gel run at 100 V, 50 mA, 135 min. Gels were
developed in 10% acetic acid to visualize S1. Labeled proteins were imaged on a UVtransilluminator. Total protein was stained using Coomassie stain. For the ACP to KS transfer
experiments (Figure. 8), proteins were separated using a 4–20% gradient HEPES-PAGE gel (100V,
50mA, 90 min).
Proteolysis
Sequencing grade modified trypsin was added to prepared samples so that the final trypsin :
ACP ratio was 1 : 50 (w/w). The mixture was incubated at 30 °C for 18 h. Digestion was
quenched by addition of an equal volume of 10% formic acid. Digests were flash frozen in liquid
nitrogen and stored at −20 °C until analysis.
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Affinity purification of holo-ACPs
Lactam modification of ACPs
Unless otherwise stated, phosphate buffer refers to 100 mM, pH 7.0 phosphate. 1 mL of an 80 :
20 mixture of holo : apo-ACP2 (25 μM total protein ) was equilibrated at ambient temperature
for 15 min in phosphate buffer containing 2.5 mM TCEP. 6 (25× with respect to total ACP
concentration) was added and the mixture was equilibrated at ambient temperature for 1 h. To
remove excess 6, the mixture was loaded into a 3kDa NMW concentrator and the volume
reduced to 100 μL by spinning in a centrifuge cooled to 4 °C. The mixture was diluted to 500 μL
with phosphate buffer , and then concentrated to 100 μL again. This process was repeated a
total of 3 times. Protein was removed from the concentrator by inverting it and spinning . The
concentrator was then washed several times with phosphate buffer which was added to the
protein sample. The filtered protein was reconstituted to 900 μL.[3 + 2] Cycloaddition In a
separate microfuge tube, DMSO (100 μL), S2 (50× with respect to protein ), THPTA33(1.1 mM),
NaAsc (10 mM), and CuSO4 (1 mM) were combined. Best results are obtained if these reagents
are first combined in a separate container and then added to the protein . The combined click
reagents are added to the protein from the previous step and allowed to react at ambient
temperature for 6 h. Excess biotin reagent was removed using the same procedure for the
removal of excess lactam . The modified protein was reconstituted to 1000 μL in phosphate
buffer .
Immobilization of modified ACPs
Streptavidin Sepharose High Performance (10× with respect to protein ) was washed 3× with
1000 μL of phosphate buffer and the supernatant was removed. The modified protein from the
previous step was added to the beads, and the mixture equilibrated at ambient temperature for
60 min with agitation on an orbit shaker. The supernatant was removed and the beads were
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washed 5× with 1000 μL of phosphate buffer , 5× with 1000 μL of TRIS buffer (100 mM, pH 9.0),
and once with 1000 μL of 100 mM TRIS, +10 mM N2H4, pH 9.0.
Elution of immobilized ACPs
The washed beads from the previous step were resuspended in 1000 μL of 100 mM ammonium
formate containing 100 mM N2H4 (100 mM pH 9.0) and equilibrated overnight at 4 °C with
agitation on an orbit shaker. Eluted protein was concentrated in a 3kDa NMW concentrator and
subjected to buffer exchange for further experiments, or combined with TCEP for direct infusion
LC-MS experiments.
Fluorescent assay for ACP to KS transfer
Holo-ACP2 (25 μM) was labeled with 10 equivalents of 6 followed by [3 + 2] cycloaddition with
S2 as described above. For transfer of the fluorescent product, [KS6AT6] (25 μM) was
introduced to acyl-ACP2 (25 μM) and incubated for 1 h. For lanes 3 and 5 (Figure. 9), [KS6AT6]
was pretreated with cerulenin (5 mM) or propionyl SNAc (10 mM) for 1 h before introducing it
to acyl-ACP2. For lanes 4 and 6, acyl-ACP2 (25 μM) was mixed with cerulenin (5 mM) or
propionyl-SNAc (10 mM) followed by 1 h incubation with [KS6AT6] (25 μM). The [KS6AT6]
control (lane 7) was executed under the same acylation and click conditions as in other samples
but without the ACP or small molecule competitors.
LC-MS
Separation was performed with a Waters 1525 system. The gradient employed was A = water +
0.1% formic acid, B = acetonitrile + 0.1% formic acid, 5–95% B over 60 min with a Waters
XBridge C18 5u column (4.6 × 150 mm). Mass spectra were acquired with a Waters Micromass
ZQ mass detector in EI+ mode: Capillary voltage = 3.50 kV, cone voltage = 30 V, extractor = 3 V,
RF lens = 0.0 V, source T = 100 °C, desolvation T = 200 °C, desolvation gas = 300 L h−1,
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desolvation gas = 0.0 L h−1 The system was operated by and spectra were processed using the
Waters Empower software suite.
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CHAPTER 4
A MECHANISM-BASED FLUORESCENT TRANSFER ASSAY FOR EXAMINING KETOSYNTHASE
SELECTIVITY

4.1. Introduction

As discussed in detail in earlier chapters, the field of polyketide engineering has faced a
constant struggle to overcome often strict substrate selectivities of the critical biosynthetic
enzymes.1–7 In case of modular PKS systems, the polyketide product flow along the assembly line
is governed by shuttling of intermediates between the acyl carrier protein (ACP) and

Figure 21. Intermodular transfer in modular polyketide synthases.
A polyketide intermediate is passed from an upstream ACP to a downstream KS via the
phosphopantetheine arm of holo-ACP. Often the substrate selectivity of the acceptor KS
domain determines the efficiency of this process and controls the flow of intermediates
down the assembly line. KS = ketosynthase, ACP = acyl carrier protein, AT = acyltransferase,
DH = dehydratase, ER = enoyl reductase, KR = ketoreductase.
ketosynthase (KS) domains (Figure 21.).8-11 The KS occupies a central role in this crucial process
and has been the focus of numerous studies with the hopes of both establishing a better
understanding of natural systems and improving our ability to manipulate them.12–15 In its
simplest form, this requires a means of accurately differentiating between substrates that
acylate the KS active site-cysteine and those that do not.
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As described previously, radiolabelling traditionally used to examine KS active site
loading has significant drawbacks, including limited scope, reproducibility, and cost that can
severely constrain the scope of such analyses. More recently, a number of groups have
developed mass spectrometry-based techniques for examining KS active site acylation.13,14,16
One particularly popular approach utilizes tandem proteolysis/LC-MS to tease out differences in
loading propensities for various substrates. Despite the many advantages compared to
radiolabeling, MS-based methods still suffer from a number of important shortcomings. It is
abundantly clear that techniques capable of providing easy and reliable access to KS selectivity
profiles

are

essential

for

continued

progress

in

this

field.

With hosts of new biosynthetic systems being uncovered with constant advances in genomic
mining, the need for simple, cost-effective means of characterizing them has never been
greater. We were interested to develop an alternative means of directly determining KS
substrate selectivity using readily accessible, inexpensive reagents and equipment. Such a
method would greatly facilitate the process of high-throughput PKS investigation and allow for
broadened exploration of the rules of substrate recognition that govern small molecule output.

Figure 22. Site-selective ACP-acylation using N-activated β-lactams.
Subsequent conjugation of modified ACP to a fluorophore (red star) uses standard click
chemistry. The resulting fluorescent ACP is used as the fluorescence donor in the current
study.
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As discussed in earlier chapters, we have recently developed a series of β-lactone and βlactam probes capable of directly acylating the Ppant-thiol of holo-ACPs.17,18 Incorporation of an
alkyne functionality provides a chemical handle for conjugation with fluorophores (Figure
22.).The thioester-ACP resulting from incubation of holo-ACP with a propargyloxycarbonyl (Poc)activated β-lactam was shown to be competitive with traditional N-acetylcysteamine (SNAc)
thioesters for KS acylation. Based on these results, it occurred to us that fluorescent thioesterACPs, derived from an alkyne-bearing β-lactam, coupled with acyl-SNAc compounds, could
provide a straightforward means of examining KS selectivity in whole PKS modules. More
specifically, the degree of KS acylation for a given SNAc substrate may be assayed by introducing
a fluorescent ACP after incubation of KS and substrate and monitoring fluorescence transfer via
gel electrophoresis. The amount of fluorescence transfer would therefore indicate to what
extent the SNAc compound was accepted by the KS domain (Figure 23.). High KS-loading would
block subsequent fluorescence transfer from ACP, and thus produce little to no fluorescent

Figure 23. Schematic of mechanism-based, fluorescence transfer assay for KS-selectivity
A given KS domain is incubated with acyl-SNAc followed by addition of fluorescently labeled
ACP. The amount of fluorescence transferred from the ACP to the KS active site provides a
direct readout of the substrate tolerance for each acyl-SNAc examined. KS = ketosynthase, ACP
= acyl carrier protein, AT = acyltransferase, SNAc = N-acetylcysteimine.
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signal in the gel. Alternatively, insufficient KS-acylation with a SNAc compound would leave most
KS active sites free to accept the fluorescent substrate from ACP resulting in a bright band. This
technique would afford a direct measure of KS selectivity while circumventing the limitations of
mass spectrometry methods described above. Most importantly, the use of mechanism-based
fluorescence transfer from acyl-ACPs ensures that any fluorescence observed on the acceptor
module results solely from the KS active site and not from competing, nucleophilic surface
residues within the complex protein system.
We expect the straightforward nature of this method to permit all research labs to
explore key features of polyketide construction. Studies ranging in scope from basic KS
selectivity to more complex ACP/KS complementarity for designing hybrid systems will be
greatly simplified, ultimately leading to significant advances in PKS engineering. Herein, is
described the initial work toward designing a mechanism-based, fluorescence transfer method
for examining substrate selectivity in PKS assemblies.

4.2. Results and discussion

Figure 24. Panel of SNAc thioesters to probe chain-length selectivity
Our previous work demonstrated that 6-deoxyerythronolide B synthase (DEBS) module
2 ACP (ACP2) could efficiently transfer a β-lactam-derived fluorescent probe to the KS active site
of the DEBS module 6 KSAT19 didomain (KSAT6).18 Since a careful choice of the donor ACP is
critical for success using this technique, we decided to begin with this ACP/KS pair for proof of
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Figure 26. Fluorescence transfer from ACP2 to KSAT6 with variable conc. of 1
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with
compound 1. Bright bands indicated little to no KS loading. Lane 1 corresponds to the
positive control where no compound 1 is added. Numbers at the top indicate the
concentration of compound 1 added to KSAT6. Right figure is full PAGE gel stain.

Figure 25. Fluorescence intensity measurements for KS acylation
Fluorescence intensities for the above gel were obtained via fluorescence analysis using
the ImageJ software. % KS acylation for each concentration of compound 1 assayed was
calculated by subtracting the % of maximum fluorescence (determined by comparison
to the control lane) for each band from 100%. A plot of % Acylation
versus compound 1 concentration is shown below.
principle studies. We had previously shown that fluorescence transfer from ACP2 to KSAT6 was

exclusive at the active-site as no transfer occurred in the presence of the KS active site
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inhibitor cerulenin, and was complete in as little as 30 min. Encouraged by the impressive
speed and specificity of this process, we commenced the development of a mechanism-based
fluorescence transfer assay capable of directly probing the influence of substrate structure (i.e.
chain length, sterics, and electronics) on KS loading.
Based on the knowledge of biosynthestic process of DEBS, we made some initial
hypothesis to start with. Firstly, we expected that longer chain substrates would be preferred
based on the structure for the natural hexaketide recognized by module 6 KS. In addition,
module 5 incorporates a methylmalonyl-extender unit which, following elongation, is passed to
module 6. As a result, we further hypothesized that α-branched thioesters may be particularly

Figure 27. Fluoscence transfer from ACP2 to KSAT6 with compounds 1-6
KSAT6 is pretreated with compounds 1-6. (Left) Lack of fluorescence indicates near
quantitative acylation of the KS active site with compound 1. Bright bands indicated little to no
KS loading. Lane 1 corresponds to the positive control where no acyl-SNac is added. Numbers
at the top indicate which compound KS was treated with prior to addition of fluorescent ACP.
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well-suited for acylating the KS domain. Our fluorescence transfer method would allow us to
readily observe these tendencies and, more importantly, provide high-resolution information as
to their limits.
Since PKS intermediates are of variable chain lengths at different stages of processing,
we wished to begin by examining this simple aspect of chain length preferences for KSAT6. A
panel of SNAc thioesters derived from straight-chain carboxylates was prepared (Figure. 24).
Before we could begin, however, it was necessary to determine an appropriate acyl-SNAc
concentration where subtle differences in KS-loading could be readily observed. Fluorescently
labeled ACP was prepared as previously described by reacting holo-ACP2 with Npropargyloxycarbonyl-β-lactam followed by Cu-catalyzed [3 + 2] cycloaddition with rhodamine
azide (see Figure. 21).20–22 Excess click reagents were removed via filtration to avoid any
complications during the assay. To determine the optimal substrate concentration for KSselectivity studies, compound 1 was introduced to KSAT6 at concentrations ranging from 630
μM to 10 mM. After 1 h incubation, a slight excess, relative to KSAT6, of fluorescent ACP2 was
added for 30 min and the protein components were subsequently separated and analyzed by
SDS-PAGE. From these data, it was determined that the inflection point between fully loaded
and unloaded KS corresponded to a substrate concentration of roughly 2.5 mM for compound 1
(Figure 25.). The fluorescence intensities were analyzed using ImageJ software which shows
trends consistent with the visual results. This analysis suggests that the visual read-out of this
method is at least pseudo-quantitative and can be used with good confidence for comparison of
different substrates.
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The variable chain length SNAc compounds (1–6) were subjected to the same analysis as
above using 2.5 mM of each. To our satisfaction, a clear preference for longer chain substrates
was observed (Figure 27.). Given that DEBS module 6 KS normally accepts a hexaketide
intermediate from module 5, these results are consistent with what might be expected of

Figure 28. Panel of SNAc thioesters to probe α- and β-branching selectivity
modules further down the biosynthetic assembly line. Most importantly, the observed trend
was reproducible over multiple, separate runs (Figure. 27.). It should be noted that previous
attempts on our part to monitor KS-loading with compounds 5 and 6 via tandem
proteolysis/mass spectrometry were unsuccessful most likely due to precipitation of the

Figure 29. Fluorescence transfer from ACP2 to KSAT6 with 7-12
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with
compound 1. Bright bands indicated little to no KS loading. Lane 1 corresponds to the positive
control where no acyl-SNac is added. Numbers at the top indicate which compound KS was
treated with prior to addition of fluorescent ACP. (Right) PAGE full gel stain
acylated KS active site fragment.
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We were highly encouraged from these results and were excited to examine the effects
of more complex structural components on KS-loading. As PKS enzymes often display the ability
to identify and distinguish α- and β-position substitutions, we were interested in uncovering any
substrate preferences for branched alkyl-SNAc compounds. A small panel of these compounds

Figure 30. Panel of SNAc thioesters tp probe p-substituted aryl groups
was prepared with variable branching at both the α- and β-positions of the carbonyl (Figure. 28).
Since the natural polyketide intermediate accepted by DEBS module 6 KS harbors an α-methyl
group, it is not surprising that compounds 9, 11, and 12 appear to load KSAT6 quite efficiently
while compounds 7 and 8 are not as effective (Figure. 29). The cyclopropyl-containing
compound 10, however, is very interesting. Despite the presence of an α-branch, this substrate
clearly behaves more like those without α-substituents. It is our thought that this may arise from
the extreme cyclopropane bond angles which might alter the side chain geometry to the point
where the KS active site does not recognize any branching. Regardless of its origins, this is a
rather remarkable response to very subtle differences in structure between isopropyl and
cyclopropyl groups.
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Having analyzed structural aspects, we wanted to extend the idea to examine electronic
aspects of KS-acylation. Using a phenyl ring as a starting template we wanted to prepare a
panel aromatic compounds bearing various electron withdrawing and donating groups to vary
the extent of activation and deactivation, respectively. A set of acyl-SNAc compounds was
prepared with an assortment of p-substituents for comparison to the parent phenyl ring of
compound 13(Figure 30). From the data, it appears that all p-substituents confer at least a slight
reactive advantage relative to the unsubstituted phenyl ring (Figure 31). To our delight, the
nitrophenyl compound 16 is most reactive as might be expected from the increased carbonyl
electrophilicity offered by the electron withdrawing nature of the nitro group. Clearly, the
electronics of the thioester play a significant role in KS acylation, but without structural
information regarding the active site binding interactions of each of these substrates, it is
difficult to speculate further. Taken together with the results from the chain length and
branching studies, this method is capable of generating a wealth of information regarding KS
selectivity in short order with minimal cost and synthetic manipulation. However, to showcase
its maximum value for examining substrate tolerance in polyketide biosynthesis, we felt it

Figure 31. Fluorescence transfer from ACP2 to KSAT6 with 13-18
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with
compound 1. Bright bands indicated little to no KS loading. Lane 1 corresponds to the
positive control where no acyl-SNac is added. Numbers at the top indicate which compound
KS was treated with prior to addition of fluorescent ACP. (Right) PAGE full gel stain.
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appropriate to move away from didomains in favor of full PKS modules.
To extend the scope of this method to the next level of complexity we wished to apply it
to full module. Keeping consistent with previous data sets, we reasoned that DEBS module 6
would be the most appropriate target for this study. This module contains a ketoreductase, acyl
carrier protein, and thioesterase domain in addition to the KS and AT present in the didomain
construct. The apo form of ACP was expressed and used for this study to avoid any competition
with the native ACP of this module. In addition, the potential for fluorescence transfer from
ACP2 to the thioesterase domain, positioned at the C-terminus of DEBS module 6, prompted us

Figure 32. Fluorescence transfer from ACP2 to apo-Mod6 with 1-18
(Left) Lack of fluorescence indicates near quantitative acylation of the KS active site with
compound 1. Bright bands indicated little to no KS loading. Lane 1 corresponds to the
positive control where no acyl-SNac is added. Numbers at the top of each gel indicate which
compound module 6 was treated with prior to addition of fluorescent ACP. Overall trends in
each gel are consistent with what was observed for KSAT6 above indicating that the
presence of DH, ER, KR, and ACP domains does not significantly alter KS-selectivity. (Right)
PAGE full gel stains.
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to omit this entity from the construct used in this study. With the optimized full module in hand,
the same 18 probes used to probe KSAT6 selectivity were applied.
Overall, it was observed that the general trends observed for KS-selectivity in the
didomain precisely tracked those for the intact module although the contrast between “good”
and “bad” substrates is slightly diminished (Figure 32.). The preference for both longer chain
and α-branched substrates is again evident and the remarkable distinction between isopropyl
and cyclopropyl groups appears consistent. The role of electronics in KS-acylations is
demonstrated by the observed preference for the nitrophenyl-containing compound 16 over all
other aryl-SNAc substrates. Taken together, these results offer a clear picture of the substrate
scope tolerated by this KS in two unique environments. The fact that the observed trends are
consistent between the didomain and intact module provides credence to the use of “broken
modules” for this kind of analysis and for its future applications.

4.3. Conclusion

We describe the development of a mechanism-based, fluorescence transfer assay for
substrate selectivity in KS domains. It is a great application of the technique of ACP-acylation
with β-lactams generating functional fluorescently labeled intermediates, as described in
Chapter 3. This technique in its current form, provides a simple, qualitative output without the
need for expensive reagents or equipment. The KS-selectivity studies are an example of the vast
and diverse number of applications to which this method can be extended, including: (1) further
examination of substrate attributes (i.e. stereochemistry, heteroatom incorporation, etc.), (2)
KS/ACP complementarity, (3) determining the impact of substrate binding pocket mutations
within KS domains on substrate tolerance, and (4) assessing the influence of active-site
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mutagenesis on downstream KS substrate selectivity. The work described here properly lays the
necessary groundwork toward each of these endeavors. In all, we expect this method to
significantly aid in the study of new and existing PKS systems leading to improved understanding
of how these extraordinary biosynthetic machines function.

4.4. Experimental Details

Protein expression
ACP2 was expressed from pNW06,8 ACP3 was expressed from pVYA05.19 [KS6AT6] was
expressed from pAYC11.12apo-ACPs were harvested from E. coli BL-21 and holo-ACPs were
harvested from E. coli BAP-1.25 pNW06 and pVYA05 contain kanamycin resistant vectors.
Cloning (pTL-DM6)
Cloning of DEBS-Mod 6 (without TE domain) was done by PCR on pRSG54 (a gift from Professor
Khosla, which encodes for DEBS Mod 6+TE). Using the primer DEBS-M6-NdeI-F1:
TTTTTTCATATGGACCCGATCGCGATCGTCGGCATG,

and

DEBS-M6-HindIII-R1:

AAAAAAAAGCTTGAGCTGCTGTCCTATGTGGTCGGC, PCR was performed in a 50 μL reaction
mixture containing: 1 × Phusion GC buffer, 0.2 mM dNTP, 0.2 mM MgCl2, 15% Glycerol, 1 μM of
each primer, 1 U Phusion Hot Start II DNA polymerase (Thermo scientific), and approximately
300 ng of pRSG54 DNA. PCR amplicon of 4215 bp was obtained after 35 cycles PCR amplification.
The DNA amplicons were excised and purified by using QIAquick Gel Extraction Kit (QIAGEN,
Germany) and then directly subjected to double restriction enzyme digestion of NdeI and
HindIII. The digested product was ligated to pre-digested pET-21b to obtain pTL-DM6.
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Protein purification and isolation
Bacteria were grown in 1 L shake cultures of LB-antibiotic media at 37 °C in an incubating shaker
until the OD600 was between 0.6 and 0.8. Over expression was induced with 200 μL of 1 M IPTG
(per liter of culture) and carried out at 18 °C for 18 h. After this point all work was carried out at
4 °C. Cells were pelleted by spinning at 5000 RPM for 10 min and resuspended in 50 mL of lysis
buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM β-glycerophosphate, 1 mM sodium Na3VO4, 1 μg mL−1 leupeptin, pH 7.5).
Cells were lysed using an ultrasonic converter. The lysate was pelleted at 10 000 rpm for 60 min.
The supernatant was equilibrated with 3 mL of Ni-NTA slurry (per liter of culture) for 60 min by
stirring with a PTFE-coated stir bar at minimal speed. The mixture was then poured into a fritted
column and the supernatant eluted. The resin bed was washed with two 15 mL portions of wash
buffer (50 mM phosphate, 300 mM NaCl, 20 mM imidazole, pH 8.0), and eluted with 3 mL (per
liter of culture) of elution buffer (50 mM phosphate, 300 mM NaCl, 250 mM imidazole, pH 8.0).
The purified protein was loaded into a 3 kDa NMW centrifugal concentrator and diluted to 15
mL with storage buffer (100 mM Tris, 1 mM EDTA, 1 mM dithioerythritol, 10% glycerol pH 8) and
spun until the final volume was ≤500 μL. Dilution and filtration was repeated a total of three
times. Protein concentration was determined by Bradford assay with a BSA standard curve.
Proteins were flash frozen and stored at −80 °C until use.
Fluorescence transfer assay
Unless otherwise stated, phosphate buffer refers to 100 mM, pH 7.0 phosphate. ACP2 (25 μM
total protein) was equilibrated at ambient temperature for 15 min in phosphate buffer
containing 2.5 mM TCEP. Poc β-lactam (10× with respect to total ACP concentration) was added
and the mixture was equilibrated at ambient temperature for 45 min. Rhodamine Azide (2× with
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added
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to samples which had been labeled with 6. The reaction was performed at ambient temperature
for 45 min. To remove excess Poc β-lactam and Rhodamine Azide, the mixture was loaded into a
3 kDa NMW concentrator and the volume reduced to 100 μL by spinning in a centrifuge cooled
to 4 °C. The mixture was diluted to 500 μL with phosphate buffer, and then concentrated to 100
μL again. This process was repeated a total of 5 times. Protein was removed from the
concentrator by inverting it and spinning. For transfer of the fluorescent product, [KSAT6] or the
full module (25 μM) was pre-treated with respective SNAc (2.5 mM) derivatives for 1 h. This
mixture was introduced to filtered acyl-ACP2 and incubated for 30 min. The [KS6AT6] and apoMod6 control was executed under the same acylation and click conditions as in other samples
but without the SNAc derivative and therefore represents full acyl transfer.
Chromophore attachment
The reaction was carried out at 25 μL, final concentrations reported. Rhodamine Azide, (2× with
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added
to samples which had been labeled with 6. The reaction was performed at ambient temperature
for 45 min.
Gel assay
Labeled samples were diluted to 20 μL with gel-loading buffer. Proteins were separated using a
4–20% gradient HEPES-PAGE gel (100 V, 50 mA, 70 min). Gels were developed in 10% acetic acid
to visualize Rhodamine Azide. Labeled proteins were imaged on a UV-transilluminator. Total
protein was stained using Coomassie stain.
Prop-2-yn-1-yl 2-oxoazetidine-1-carboxylate: 2-Azetidinone (107 mg, 1.5 mmol) was dissolved
in THF (7 mL) at −78 °C. LiHDMS (330 mg, 2 mmol) dissolved in THF (2 mL) was added in portions
over 10 min and the reaction mixture was stirred for 30 min. Propargyl chloroformate (181 mg,
1.5 mmol) dissolved in THF (2 mL) was added in portions over 10 min and the reaction mixture
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was stirred at −78 °C for 2 h then allowed to warm to ambient temperature. The reaction
mixture was diluted with water and extracted with DCM (50 mL × 3). The combined organic
layers were washed with brine and dried over Na2SO4. Solvent was removed by rotary
evaporation. Purification of crude product by flash chromatography with 95 : 5 DCM–Methanol
yields (106 mg, 0.69 mmol) 46% of product as pale yellow solid.
Sulforhodamine-B azide: 3-Azido-1-aminopropane23 (22 mg, 0.22 mmol) and triethylamine (51
mg, 0.5 mmol) were dissolved in 1 mL of 5 : 1 DCM–DMF and cooled to 0 °C. Sulforhodamine B
sulfonyl chloride [mixture of ortho- and para-sulfonyl chloride isomers] (115 mg, 0.20 mmol)
was added portion-wise over ca. 30 min and stirred overnight at room temperature. Solvent was
removed in vacuo, and the product was purified by flash chromatography over silica gel with 90
: 5 : 5 DCM–Acetonitrile–Methanol mobile phase. The ortho isomer was distinguished by its
reversible color change in pH 9.0 buffer.24Para isomer: (22 mg 0.034 mmol) 17%, ortho isomer
(18 mg, 0.028 mmol) 14%. Both obtained as a red solid with a metallic green luster. The ortho
isomer was found to perform best in the click reaction and was utilized for labeling experiments.
General method for preparation of all N-acetylcysteamine (SNAc) thioester derivatives
To a solution of triethylamine (2.80 mmol) in dichloromethane (10 mL) was added the
appropriate acid (1.40 mmol), (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.40
mmol), 1-hydroxybenzotriazole (HOBt) (1.40 mmol) and N-acetylcysteamine (SNAc) (1.35 mmol)
under argon. The reaction mixture was stirred overnight. The organic layer was washed with
saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then dried over anhydrous
sodium sulfate, concentrated under vacuum, and purified by flash column to provide the final
product in pure form.
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CHAPTER 5
EXAMINING KS SELECTIVITY IN FLUVIRUCIN B1 SYNTHASE

5.1 Introduction

Over the past several decades, researchers have devised numerous methods for
manipulating PKS processes in an effort to diversify product structure and, ultimately, biological
activity.1-5 In the effort to capture the true engineering potential of PKSs, numerous techniques
have been explored for separation, fusion, and rearrangement of component enzymes.
The domain swapping technique involves physically replacing an individual PKS enzyme
with one from another synthase. Most commonly used for AT domains, the key to effective
domain swapping is comprehensive knowledge of domain boundaries such that the surrounding
enzymes are unaffected. The primary downside to this procedure is that heterologous domains
often behave differently in their new environment. The domain addition technique is generally
employed when an increase in enzyme activity is desired. Many attempts have been made to
incorporate KR, DH, and ER domains into modules where they are absent but the most effective
strategy for domain addition involves replacing the entire module with a heterologous one
bearing the appropriate tailoring domains. Although some success has been realized with these
techniques, decreased yields of engineered products have limited their scope and efficacy. In
both cases, introduction of heterologous enzyme components often leads to disruption of
three-dimensional structure and causes protein communication issues between native and
heterologous components, often impeding the flow of intermediates within and between
modules. These factors together contribute to the issue of decreased yields.6-11
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The simplest technique of all is the domain deletion/inactivation, functionally the
opposite of domain addition. The activity of any module containing at least one tailoring domain
(KR, DH, or ER) can be altered via mutation of active site residues or removal of the entire
enzyme. It has been shown, however, that mutation (inactivation) provides significantly higher
product yields compared to removal (deletion), owing largely to the fact that the former method
maintains the native three-dimensional structure of the engineered module. This observation
together with the domain addition and swapping data, form the initial motivation and basis of
our hypothesis. We were convinced that disruption of PKS structure and recognition motifs
plays a significant role in diminished product yields.
For modular polyketide synthases this means unearthing assemblies which bear the full
complement of tailoring domains (KR, DH, and ER), similar to mammalian FAS, in most, if not all,
active modules. In contrast to current methods, carefully executed mutagenesis of key native
active site residues should result in all possible β-functionalities. The key advantage will be the
ability of leaving the native protein-protein interactions intact (Figure 33). Therefore, we were
particularly interested in PKSs that produce largely unfunctionalized polyketides (i.e. methylenes
at most β -positions) and may provide optimal engineering potential.
Our lab has recently identified the gene cluster for a modular PKS responsible for the
production of fluvirucin B1 in Actinomadura vulgaris (Figure 34.).12-14Fluvirucin B1 is a 14membered macrolactam with moderate to good antifungal and antiviral activities. It is an
interesting PKS system with many unique biosynthesis attributes. It contains 5 modules of which
4 contain the full set of PKS tailoring domains. According to our hypothesis, it is an ideal system
for engineering strategy of single domain inactivation via site-directed mutagenesis.
We were motivated to explore the biosynthetic origin of fluvirucin B1 with the ultimate
goal of providing a platform for polyketide engineering that circumvented the need for
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incorporation of heterologous domains to achieve maximal product diversity. By using the
strategy of active-site mutagenesis, we can inactivate one enzyme at a time to access all the β functionalities possible (Figure 33.). The fluvirucin polyketide synthase offers nearly double the
product scope of the most commonly used assembly, 6-deoxyerythronolide B synthase, due to
the significantly increased number of ketoreductase, dehydratase, and enoyl reductase domains
within the cluster. By using this approach, there is a potential to produce large library of
macrolactam variants. Such a system provides an ideal platform for conducting various kinds of
PKS investigations with the current set of β-lactam based molecular tools that we have
successfully developed.
The lack of additional ring functionalities caught our interest as we hypothesized that
nearly all active modules should contain the FAS-like domain organization where KR, DH, and ER
are all present. That is another interesting feature of this PKS system in terms of resemblance to
FASs. If one were to consider PKS systems as evolutionarily connected to FAS, the fluvirucin
synthase may represent an early link between the two.

These investigations of their

biosynthetic mechanisms can help shed some light on this aspect as well.

Role of substrate selectivity

Figure 33. Schematic for mutational inactivation strategy of fatty acid-like PKS modules
Novel compound production by designing alterations in chemical structure at the genetic level.
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Flow of intermediates along a PKS system heavily relies on communication between
neighboring enzymes). Many groups have focused on determining the associated recognition
motifs that govern these interactions.15-17 However, we were interested in obtaining product
diversity without reinventing enzyme architecture and work with what nature has already
provided. To do so, a strategy where product diversification is solely the result of domain
inactivation must be implemented. Without disturbing the protein-protein interactions by
leaving all recognition interfaces in their natural forms, the problem of producing and shuttling
intermediates along the synthase will now be reduced to one of substrate selectivity. Above all,
it will rely on the ability of downstream KS to accept modified intermediate substrate handed
down by an upstream mutant module.
Instead of using radiolabelled substrates that would require elongation and cyclization
events or struggle with LC/MS to tease out differences in small molecular masses of the highly
similar intermediates, it occurred to us that the mechanism-based fluorescence transfer assay to
investigate KS selectivity as described in Chapter 4 could be of great assistance for this purpose
18

. Firstly, we prepare a library of potential substrates with β-functional modifications for each of

the KSs and use them to assay KS compatibility for these novel β-carbon analogues that they
would encounter during biosynthesis in a modified, mutant module. In this manner, this assay
can be used as a prototype that mimics substrate transfer and intermediate flow to test the
effectiveness of the mutagenesis in the module. In addition to delivering improved yields of
engineered products, such a system will, for the first time, provide a systematic means of
assessing the relative contribution of substrate selectivity to the flow of structures from one
module to the next in full-length PKS.
The ultimate test of this methodology is to combine high yielding single mutants to build
increased complexity and diversity in polyketide structure by using a multiple-plasmid system to

84

incorporate more than one mutation. In which case, the KS-selectivity assay can be employed to
gain insight regarding behavior of downstream enzyme to a particular upstream structural
modification caused by a mutation in an intact PKS and consequently help in logical designing of
these complex assemblies. In this manner, our primarily goal is to use this KS-selectivity assay as
a tool to lay the groundwork to ensure success of the product diversification strategies. But in
turn, this will provide a wealth of information regarding influence of upstream modifications on
downstream enzyme activity and help improve our understanding of the biosynthetic machinery
and its working.

5.2. Results and discussions

From the core structure of fluvirucin B1, we hypothesized that the producing PKS would
consist of five extender modules assuming that a β-alanine derivative is used as a starter unit in
the process. The sole hydroxyl group would therefore arise from a module harboring only a KR
domain while all other extender modules would contain the full complement of KR, DH, and ER
domains (Figure 34.). Based on the positions of macrolactam ring substituents, we expected
that: (1) the first and last modules contained ethylmalonyl-specific AT domains, (2) the second
and fourth modules incorporated malonyl groups, and (3) the third module utilized
methylmalonate (Figure 34.). Finally, ring closure was most likely achieved via a C-terminal
thioesterase (TE) domain as is the case with similar macrocyclic polyketides.19-21 To test these
hypotheses and determine the precise arrangement of enzymes within the assembly, we set out
to identify and characterize the fluvirucin B1 biosynthetic gene cluster.
To do so, the producing organism, Actinomadura vulgaris, was cultured following
published procedures.13-15 Genomic DNA was isolated and sequenced affording 436,311
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overlapping sequence fragments. These sequences were partially assembled resulting in 444
consensus sequences ranging in size from 5000 to 170,000 base pairs. The relatively large size
of PKS constructs allowed us to quickly identify potential hits by searching each assembled
sequence for open reading frames of at least 4000 base pairs. Our search identified several PKS
gene clusters, one of which contained the expected size and module composition of the
proposed fluvirucin PKS.
Three modular PKS genes, flu A-C, were found to contain an arrangement and
composition of domains consistent with the expected fluvirucin PKS assembly22 (Figure 34.).
FluA contains modules 1 and 2 of the fluvirucin B1 assembly. As expected, module 1 has the full
compliment of tailoring domains (KR, DH, and ER) while module 2 possesses only a KR domain
putatively leading to the sole hydroxyl group on the macrolactam ring. A single loading ACP is
found at the N-terminus of FluA similar to the vicenistatin PKS which utilizes a β -methyl- β alanine starter unit.23 FluB contains modules 3 and 4 of the fluvirucin B1 PKS. Both modules
contain KR, DH, and ER domains as would be predicted from the fluvirucin core structure.
Finally, FluC consists of module 5 and a C-terminal TE domain. Module 5 again has all three
tailoring domains consistent with the lack of functionality at the corresponding macrolactam
ring position.
Fluvirucin B1 PKS Genes
As predicted, the fluvirucin B1 polyketide synthase consists of 5 extender modules
flanked by an N-terminal loading ACP and C-terminal TE domain. All but one of the extender
modules contains a KR, DH, and ER domain in addition to the required KS, AT, and ACP leading
to the relatively unfunctionalized nature of the macrolactam product.

Based on this

arrangement of composition of modules, β-alanine is expected to serve as the starter unit for
fluvirucin B1 biosynthesis.
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Figure 34. The putative fluvirucin B1 PKS
The assembly consists of five extender modules flanked by an N-terminal loading ACP and Cterminal thioesterase (TE) domain. FluA consists of the loading ACP, module 1 and module 2.
FluB consists of modules 3 and 4. FluC consists of module 5 and the TE domain.

AT Selectivities
Extender unit selectivity for AT domains provides compelling evidence for any link between a
given PKS assembly and its associated polyketide product. Using, the SEARCHPKS program
developed by Mohanty and coworkers, probable coenzyme A substrates were determined for
each of the five putative fluvirucin B1 synthase AT domains.24 To our delight, all of the predicted
AT domain specificities were consistent with the fluvirucin B1 core structure. Specifically,
modules 2 and 4 showed high sequence similarity with malonyl-specific AT domains while
module 3 was predicted to utilize methylmalonyl-CoA. Modules 1 and 5 returned a single hit for
ethylmalonate specificity amidst several methylmalonyl-specific AT domains. This is most likely
due to the considerably lower abundance of ethylmalonyl-specific ATs relative to
methylmalonyl-specific ones rather than a true indication of relaxed specificity.
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a)

b)

FluAT3 substrate selectivity

c)

Figure 35. FluAT specificity studies
a) Schematic diagram of AT substrate selectivity studies of modules 1, 3, and 5 b)
representative LC-MS analysis of FluAT3 loading c) Results of AT studies, red checks indicate
that the substrate shown on the left is transferred from the indicated AT to the ACP domain,
whereas a black X indicates that no substrate transfer was observed. FluATX = fluvirucin AT
domain from module X
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In order to examine the AT specificities, the N-acetylcysteamine(SNAc) analogues of
ethylmalonyl-CoA, methylmalonyl-CoA and malonyl-CoA were prepared. The ATs from Moduke
1, 3 and 5 were each tested for their ability to load their cognate ACP with these three SNAc
compounds (Figure 35.). The ACP modification was observed by LC-MS as described previously.
To our delight, as expected from the sequence similarity studies, AT1 and AT5 loaded
ethlymalonyl product and AT3 loaded methylmalonyl product. These observations about the
unusual substrate preferences further give credence to the enzyme identities.
Flu KS substrate selectivity
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Figure 36. Panel of substrates for KS Module 3 of Fluvirucin B1 synthase
As outlined earlier, upon characterization of this unique PKS system, our aim was to test
the tolerance of KSs by applying the technique developed and described in Chapters 3 and 4.
This method will assess the KS selectivities towards a range of altered β-functionalities with its
original substrate motif as reference. An appropriate acyl carrier protein will be chosen to
generate a β-lactam based fluorescent acyl-ACP to act as a donor in this process. By tracking the
extent of fluorescence transfer by the ACP to the KS active-site, we can assess the extent of KS
loading by each of the test substrates. Such a straightforward analysis will provide key insight
into KS preferences for different β-carbon bearing intermediates as well as shed light about the
KS preferences compared to other KSs in the same PKS. All these trends and observation would
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be of great value in learning about the preferences and functioning of key enzymes of this novel
PKS system for which no prior information is available.
For a preliminary screen, we prepared a small panel of SNAc thioesters (Figure 36.).
They incorporate different variations of hydroxyl, enoyl and fully reduced carbon at the beta
position. This panel is a good starting point to investigate the preferences of KS for variation of
functionalities at the beta position and be used further as a framework for testing the other four
KSs in this PKS system. These preliminary experiments will provide some insight into the extent
and contrasts of tolerance exhibited by these different KSs. To begin with, we started with the
KS of module 3. We conducted a few experiments with buytryl analogues, namely: (R)and (S)hydroxyl at β-position.
As predicted from its biosynthesis flow chart, it accepts a substrate with an (S)-hydroxyl
group at its β position whereas the other stereoisomer loads the KS active site poorly resulting
in substantial fluorescence transfer(Figure 37.). There results have been confirmed by LC-MS
experiments where FluKSAT3 is incubated with both the stereoisomers and KS active site
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modification is analyzed by mass spectrometry (Figure 38.).
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Figure 37. Fluorescence transfer from ACP3 to FluKSAT3
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5.3. Conclusions

In summary, we have identified and characterized the putative PKS genes associated
with fluvirucin B1 aglycone biosynthesis in A. vulgaris. The number and composition of modules
as well as predicted AT specificities are consistent with the fluvirucin B1 structure.

The

abundance of tailoring domains within the assembly is expected to provide increased
engineering potential, through straightforward active site mutagenesis. The assay developed
with β-lactams derived functional acyl-ACPs for examining KS-selectivity is being applied to
fluviricin KSs to understand effects of introducing novel β-functionalities on downstream KSs in
terms of substrate preferences. Some preliminary work has been done with Flu KSAT3 to ensure
feasibility and reproducibility and work is underway to expand the application to all the Flu KSs.
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Figure 38. LC-MS loading experiments of Flu KS
LC–MS data for module 3 KS-acylation with (R)-3-hydroxybutyryl-SNAc (top) and (S)-3hydroxybutyryl-SNAc (bottom). Only the (S)-isomer is accepted by module 3 KS as is
expected from the fluvirucin B1 structure. Peaks are labeled with the corresponding
acylated or unacylated KSAT3 didomain. All peaks are m/z = +2. Table below shows the
masses for loading of KS active-site.

Table 4. KSAT3 loading with 3-hydroxy-butyric-SNAc
Protein

Probe

Mass expected(m/z, z=+2)

KSAT3

-

1667.6

KSAT3

3-hydroxy-butyric-SNAc

1710.1
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5.4. Experimental Details
General method for preparation of all N-acetylcysteamine (SNAc) thioester derivatives
To a solution of triethylamine (2.80 mmol) in dichloromethane (10 mL) was added the
appropriate acid (1.40 mmol), (3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.40
mmol), 1-hydroxybenzotriazole (HOBt) (1.40 mmol) and N-acetylcysteamine (SNAc) (1.35 mmol)
under argon. The reaction mixture was stirred overnight. The organic layer was washed with
saturated NaHCO3 solution, 0.1 N HCl solution and brine. It was then dried over anhydrous
sodium sulfate, concentrated under vacuum, and purified by flash column to provide the final
product in pure form.
Fluorescence transfer assay
Unless otherwise stated, phosphate buffer refers to 100 mM, pH 7.0 phosphate. ACP2 (25 μM
total protein) was equilibrated at ambient temperature for 15 min in phosphate buffer
containing 2.5 mM TCEP. Poc β-lactam (10× with respect to total ACP concentration) was added
and the mixture was equilibrated at ambient temperature for 45 min. Rhodamine Azide (2× with
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added
to samples which had been labeled with 6. The reaction was performed at ambient temperature
for 45 min. To remove excess Poc β-lactam and Rhodamine Azide, the mixture was loaded into a
3 kDa NMW concentrator and the volume reduced to 100 μL by spinning in a centrifuge cooled
to 4 °C. The mixture was diluted to 500 μL with phosphate buffer, and then concentrated to 100
μL again. This process was repeated a total of 5 times. Protein was removed from the
concentrator by inverting it and spinning. For transfer of the fluorescent product, [KSAT3] was
pre-treated with respective SNAc (2.5 mM) derivatives for 1 h. This mixture was introduced to
filtered acyl-ACP2 and incubated for 30 min. The [KSAT3] control was executed under the same
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acylation and click conditions as in other samples but without the SNAc derivative and therefore
represents full acyl transfer.
Chromophore attachment
The reaction was carried out at 25 μL, final concentrations reported. Rhodamine Azide, (2× with
respect to Poc β-lactam), sodium ascorbate (1 mM), and copper(II) sulfate (1 mM) were added
to samples which had been labeled with 6. The reaction was performed at ambient temperature
for 45 min.
Gel assay
Labeled samples were diluted to 20 μL with gel-loading buffer. Proteins were separated using a
4–20% gradient HEPES-PAGE gel (100 V, 50 mA, 70 min). Gels were developed in 10% acetic acid
to visualize Rhodamine Azide. Labeled proteins were imaged on a UV-transilluminator. Total
protein was stained using Coomassie stain.
ACP acylation by AT
To a mixture of ACP (50 µM) and KS-AT (2 µM) in 100mM pH 7.0 phosphate buffer (50 µL total
volume) containing 2.5 mM TCEP at 4 oC was added appropriate SNAc thioester substrate (500
µM) . The mixture was incubated 4 oC for 30 min to achieve AT assisted acylation of the ACP.
Sequence grade modified trypsin was added to prepare samples with final ration trypsin:ACP to
be 1:10 (w/w). The mixture was incubated for 60 min at 37 oC. Digestion was quenched by
addition of equal volume of 10% formic acid. Digests were stored at -80 oC until analysis.
KSAT3 loading
To a mixture of KSAT3 (25 μM) in 100 mM pH 7.0 phosphate buffer (50 μL total volume)
containing 2.5 mM TCEP at 4 oC was added appropriate SNAc thioester substrate (5mM). The
mixture was incubated at 4oC for 60 min to achieve KS acylation. Sequence grade modified
trypsin was added to prepare samples with final ratio trypsin:ACP to be 1:10 (w/w). The mixture
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was incubated for 60 min at 37 oC. Digestion was quenched by addition of equal volume of 10%
formic acid. Digests were stored at -80 oC until analysis.
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CHAPTER 6
SUMMARY AND FUTURE DIRECTIONS
Small molecule probes in the form of reactive heterocycles have been developed for
direct acylation of ACP in polyketide synthases. These probes are in the form of β-lactones and
β-lactams have been optimized to specifically target ACP Ppant thiol and introduce polyketidelike functionalities onto the ACP for further investigations. These reactive heterocycles have
been used to introduce affinity and labeling groups onto crucial enzymes of the PKS enabling
investigation of PKS biosynthesis processes.
In the first chapter, we introduced the field of polyketides and their scope and
importance as therapeutics. We introduced the major traditional methods of examining PKSs
and their shortcomings which have restricted the efforts in novel polyketide engineering. We
also introduce our hypothesis described in detail in rest of the thesis for developing a novel
approach using small molecules for examining PKS biosynthesis.
The second chapter describes use of functionalized β-lactones to achieve direct
acylation of ACP. It provides a greatly simplified alternative to achieve direct, selective acylation
of holo-ACP using readily accessible β-lactones as electrophilic partners for the PPant thiol. It
offers a synthetically straightforward means of loading key PKS components with novel
substrates.
The third chapter describes the introduction of novel β-lactam-based probes as versatile
reagents for ACP labeling as a substantial improvement over previously described β-lactones.
An versatile alkyne group is introduced to provide a handle for conjugation to fluorophores and
affinity labels. The utility of these probes for mechanistic interrogation of polyketide
biosynthesis is demonstrated by comparison to traditional probes.
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In the fourth chapter we describe the application of β-lactam probes for designing a
mechanism-based fluorescent assay for examining KS selectivity. The KS of DEBS module 6 is
examined for its ability to accept a variety of simple thioesters and some remarkable
observations are made. This technique demonstrates its utility by providing a simple, qualitative
output without need for expensive reagents. Chapter five describes the application of the assay
for examining KS selectivity to a new PKS system, Fluvirucin B1 synthase. This assay is set-up to
examine selectivities of KSs from this PKS towards a panel of β-functionalities to guide the
efforts of performing active-site mutagenesis in modules to produce novel polyketide products.
The fifth chapter extends the utility of this reactive heterocylce small molecule based
approach to examine KS selectivity in a novel PKS system. The Fluvirucin B1 synthase has been
cloned out and characterized to be used as platform for producing novel Fluvirucin B1 analogues
using an active-site mutagenesis strategy. In the absence of protein-protein interaction effects,
substrate selectivity is the key factor determining proper intermediate flow in these engineered
systems. The KS substrate selectivity of downstream enzymes has been planned to test the
feasibility of the mutagenesis strategy and determine the role of substrate selectivity. The
FluKSAT3 has been analyzed using this method demonstrating its ability to provide a simple
visual readout for the KS substrate preferences.
These preliminary studies lay a good groundwork for further extensive KS substrate
analysis. The FluKSAT3 analysis concept will be extended to all the remaining four KSs starting
with analysis of their native substrate preferences and extending it into non-native substrates
with variable β-functionalities. The information gathered about substrate preferences of all the
KSs will map out the possibilities in terms of engineering novel Fluvirucin analogues. The
availability of this critical information about KS preferences will help design of active-site
mutagenesis strategies with increased confidence in the execution of this scheme. Rather than
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embarking upon a strategy with no prior information about the enzyme selectivity, the vital
information about KS substrate preferences will definitely improve the success rate of producing
diversified and novel polyketide analogues of Fluvirucin and other known and new PKS systems
for therapeutic applications.
Another interesting application of this method could be examining the impact of
substrate binding pocket mutations within KS domains on substrate tolerance. To begin with,
crystal structures of the KS binding-site pocket will be examined and combined with homology
studies to identify some potential amino acids involve in key interactions with substrates.
Systematic mutations of these potential residues in the binding pocket of the KS can be
performed to identify actual residues responsible for substrate preferences displayed by the KS.
A series of KS mutant didomains as well as full modules will be prepared and analyzed against
various substrates by using fluorescence transfer assay. By means of a simple visual read-out,
this fluorescence assay can easily pick out KS mutants that display altered substrate tolerance
and in turn identify the residue that has undergone mutation/alteration. Overall, PKS
engineering efforts often suffer from poor yields due to lack of information about enzyme
preferences. By identifying key residues in KS that determine substrate tolerance, these residues
can be manipulated to alter substrate tolerance as necessary and greatly help PKS engineering
efforts by improving yields in new and re-engineered systems.
A great advantage of this assay is that due its flexibility, simple set-up with quick visual
read-out, it can be easily adapted to a medium/high-throughput kind of application where any
KS in question can be rapidly assessed against a large panel of natural and non-natural
substrates. This incredible feature will undoubtedly make it a popular choice for use in
performing polyketide engineering to make novel polyketide products. We expect that the
successful application of this approach will provide researchers a reliable tool to overcome the

101

challenge posed by strict enzyme selectivity and pave way to an era of highly simplified and
productive PKS engineering.
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